Processing 00000000.tx.1: Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice Hiroki Hamanaka+, Yuko Katoh-Fukui1, Kazuo Suzuki2, Mariko Kobayashi, Rika Suzuki1, Yoshiko Motegi1, Yoko Nakahara1, Aya Takeshita1, Mizue Kawai2, Koichi Ishiguro, Minesuke Yokoyama1 and Shinobu C. 

Phrase: "Altered cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "in human apolipoprotein E4 knock-in mice Hiroki Hamanaka+,"

Phrase: "Yuko Katoh-Fukui1,"

Phrase: "Kazuo Suzuki2,"

Phrase: "Mariko Kobayashi,"

Phrase: "Rika Suzuki1,"

Phrase: "Yoshiko Motegi1,"

Phrase: "Yoko Nakahara1,"

Phrase: "Aya Takeshita1,"

Phrase: "Mizue Kawai2,"

Phrase: "Koichi Ishiguro,"

Phrase: "Minesuke Yokoyama1"

Phrase: "and"

Phrase: "Shinobu C."
Processing 00000000.tx.2: Fujita Project 8 and 1Reproductive Engineering Section, Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo 194-8511, Japan, 2Pharmaceuticals Research Laboratory 1, Mitsubishi-Tokyo Pharmaceuticals Inc., Yokohama Research Center, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-8502, Japan Received 15 September 1999; 

Phrase: "Fujita Project 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709701:Project [Conceptual Entity]

Phrase: "and"

Phrase: "1Reproductive Engineering Section,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "Mitsubishi Kasei Institute of Life Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "11 Minamiooya,"

Phrase: "Machida,"

Phrase: "Tokyo 194-8511,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "2Pharmaceuticals Research Laboratory 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0022886:research laboratory [Research Activity]
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Mitsubishi-Tokyo Pharmaceuticals Inc.,"

Phrase: "Yokohama Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "1000 Kamoshida-cho,"

Phrase: "Aoba-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Yokohama 227-8502,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "15 September 1999"

Phrase: ";"
Processing 00000000.tx.3: Revised and Accepted 1 December 1999.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "1 December 1999."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The 4 allele of apolipoprotein E (apoE) is associated with an increased risk of developing Alzheimers disease (AD). 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The 4 allele of apolipoprotein E (apoE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   753   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with an increased risk of developing Alzheimers disease (AD)."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C0002395:Alzheimers disease [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0243083:associated disease [Pathologic Function]
   762   C1281905:disease risk [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   715   C0277564:Acquired disease [Disease or Syndrome]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.5: To accurately determine the isoform-specific effects of human apoE on brain functions under physiological and pathological situations, we created mice expressing human apoE4 isoform in place of mouse apoE by utilizing the gene-targeting technique on the embryonic stem cells (knock-in). 

Phrase: "To accurately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the isoform-specific effects of human apoE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on brain functions"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
  1000   C0678908:brain functions [Organ or Tissue Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0542341:Functions [Functional Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "under physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological situations,"

Phrase: "we"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "human apoE4 isoform in place of mouse apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   784   C0443526:Apolipoprotein E isoform [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   742   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "by utilizing"

Phrase: "the gene-targeting technique on the embryonic stem cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449851:Technique [Functional Concept]

Phrase: "(knock-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517676:Knock-in [Research Activity]

Phrase: ")."
Processing 00000000.tx.6: The homozygous 4 (4/4) mice correctly expressed human apoE4 in the serum and the brain. 

Phrase: "The homozygous 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygous [Organism Attribute]

Phrase: "(4/4"

Phrase: ")"

Phrase: "mice correctly expressed human apoE4 in the serum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   744   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.7: The human apoE in the brain was found primarily in the astrocytes as was the mouse apoE in the wild-type (+/+) mice. 

Phrase: "The human apoE in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "primarily in the astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004112:Astrocytes [Cell]

Phrase: "as"

Phrase: "was"

Phrase: "the mouse apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the wild-type (+/+) mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.8: In the 4/4 mice, the serum cholesterol level was 2.5-fold that of the +/+ littermate controls on a regular diet. 

Phrase: "In the 4/4 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the serum cholesterol level"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
  1000   C1287371:Serum cholesterol level [Laboratory or Test Result]
   901   C0201950:cholesterol level [Laboratory Procedure]
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1546774:Serum [Intellectual Product]
   827   C1547707:Level [Geographic Area]
   827   C1550100:Serum [Body Substance]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "2.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "that of the +/+ littermate controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "on a regular diet."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0012155:regular diet? [Food]
           Diet
  1000   C0184625:Regular diet [Daily or Recreational Activity]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.9: This marked elevation was accounted for by an accumulation of very low and low density lipoproteins. 

Phrase: "This marked elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "was"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by an accumulation"

Phrase: "of very low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442811:Very low [Finding]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "low density lipoproteins."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023823:Low-Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.10: In the brains of the 4/4 mice, however, the amounts of total cholesterol and phospholipids were significantly decreased compared with the +/+ littermates. 

Phrase: "In the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of the 4/4 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "however,"

Phrase: "the amounts of total cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with the +/+ littermates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]
Processing 00000000.tx.11: These findings indicate that cholesterol and lipid metabolism is markedly altered in the 4/4 mice. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "lipid metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "altered in the 4/4 mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0392747:Altered [Functional Concept]
Processing 00000000.tx.12: Our human apoE4 knock-in mice will be useful in clarifying the role of apoE in the etiologies of AD and cardiovascular diseases in relation to cholesterol and lipid metabolism.  

Phrase: "Our human apoE4 knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1517676:Knock-in [Research Activity]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "will"

Phrase: "be"

Phrase: "useful in clarifying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0042153:use [Functional Concept]
   718   C0457083:Use [Functional Concept]
   718   C1947944:Use [Intellectual Product]

Phrase: "the role of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the etiologies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0015127:etiologies [Functional Concept]
   966 E C1314792:Etiology [Functional Concept]
   966 E C1524003:Etiology [Conceptual Entity]

Phrase: "of AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "cardiovascular diseases in relation to cholesterol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007222:Cardiovascular Diseases [Disease or Syndrome]
   753   C0007226:Cardiovascular [Body System]
   753   C0012634:Diseases [Disease or Syndrome]

Phrase: "and"

Phrase: "lipid metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Apolipoprotein E (apoE) is a constituent of several classes of plasma lipoproteins and plays an important role in the transport of cholesterol and phospholipids among various cells of the body (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "is"

Phrase: "a constituent of several classes of plasma lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0729650:constituent [Substance]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the transport of cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "phospholipids among various cells of the body"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   714 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: It serves as the ligand that mediates the uptake of lipoprotein particles into cells via the low density lipoprotein receptor (LDLR) and the LDLR-related protein (LRP). 

Phrase: "It"

Phrase: "serves as the ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023688:Ligand [Chemical]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the uptake of lipoprotein particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "into cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "via the low density lipoprotein receptor (LDLR)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   923   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   861   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205251:low [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "the LDLR-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "(LRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.15: The brain is second next to the liver in the content of apoE mRNA (2), which is predominantly synthesized by astrocytes (3,4). 

Phrase: "The brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "second next to"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0205117:Next to [Spatial Concept]
           next
   877   C0175668:Secondary to [Temporal Concept]
       E   Secondary
   827   C0205436:Second [Quantitative Concept]
   827   C0332282:Next [Temporal Concept]
   827   C0457385:Second [Temporal Concept]
   827   C0565930:/second [Quantitative Concept]
   827   C1561503:second [Idea or Concept]
   827   C1705190:Second [Qualitative Concept]
   827   C1883708:Next [Temporal Concept]
   755 E C0027627:secondary [Neoplastic Process]

Phrase: "the liver in the content of apoE mRNA (2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0023884:Liver [Body Part, Organ, or Organ Component]
   739   C0736268:LIVER [Body Part, Organ, or Organ Component]
   739   C1278929:Liver [Body Part, Organ, or Organ Component]
   739   C2346688:LIVER [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "predominantly"

Phrase: "synthesized by astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C1883254:Synthesized [Activity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.16: Although much remains to be clarified about the lipid and lipoprotein metabolism in the brain, recent studies have revealed that apoE is present in high density lipoprotein (HDL)-like lipoprotein particles in the cerebrospinal fluid (CSF) (57). 

Phrase: "Although"

Phrase: "much"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clarified about the lipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023779:Lipid [Lipid]
   770   C2986669:Clarified [Activity]

Phrase: "and"

Phrase: "lipoprotein metabolism in the brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1158917:lipoprotein metabolism [Molecular Function]
   797   C0596215:brain metabolism [Organ or Tissue Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present in high density lipoprotein (HDL)-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "like lipoprotein particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597177:particles [Chemical Viewed Structurally]

Phrase: "in the cerebrospinal fluid (CSF)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.17: Human apoE is a 299 amino acid protein that occurs in three major isoforms (apoE2, apoE3 and apoE4) encoded by three APOE alleles (2, 3 and 4) differing with respect to the presence of cysteine or arginine at two polymorphic sites. 

Phrase: "Human apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a 299 amino acid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "occurs in three major isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205164:Major [Qualitative Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "(apoE2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052198:ApoE2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")"

Phrase: "encoded by three APOE alleles"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0002085:Alleles [Gene or Genome]
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205449:Three [Quantitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C0679058:encoded [Mental Process]
   760   C1412481:APOE [Gene or Genome]
   760   C2700640:Encoded [Activity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "differing with respect to the presence of cysteine"

Phrase: "or"

Phrase: "arginine at two polymorphic sites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.18: ApoE3, the most common isoform, has cysteine at amino acid position 112 and arginine at 158; 

Phrase: "ApoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "the most common isoform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "cysteine at amino acid position 112"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "arginine at 158"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.19: apoE2 has cysteine at both 112 and 158, and apoE4 has arginine at both sites (1). 

Phrase: "apoE2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052198:ApoE2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "cysteine at both 112"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "158,"

Phrase: "and"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "has"

Phrase: "arginine at both sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: Numerous epidemiologic studies have established that the 4 allele is associated with an increased risk of developing both familial late-onset and sporadic Alzheimers disease (AD) (810). 

Phrase: "Numerous epidemiologic studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002783:Epidemiologic Studies [Research Activity]
   827   C0014507:Epidemiologic [Biomedical Occupation or Discipline]
   827   C0014508:epidemiologic [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0699910:epidemiology [Health Care Activity]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with an increased risk of developing"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "both familial late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "sporadic Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "(810"

Phrase: ")."
Processing 00000000.tx.21: ApoE immunoreactivity has been detected in senile plaques (11) and neurofibrillary tangles (NFTs) (12), the two hallmarks of AD. 

Phrase: "ApoE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "detected in senile plaques"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0392079:Senile [Finding]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "neurofibrillary tangles (NFTs)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "the two hallmarks of AD."
Processing 00000000.tx.22: Increased plaques have been found in the brains of 4 homozygotes (13,14). 

Phrase: "Increased plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "found in the brains of 4 homozygotes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   757   C1418764:BRAIN-4 [Gene or Genome]
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0019904:Homozygotes [Organism Attribute]
   748   C0150312:Found [Quantitative Concept]
   714 E C0243095:Find [Finding]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.23: Studies have reported binding of apoE to amyloid -peptide (A) (8,15,16) and to tau protein (17), the principal constituent of NFTs. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "binding of apoE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819   C2247768:apolipoprotein binding [Molecular Function]
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) (8,"

Phrase: "15,"

Phrase: "16"

Phrase: ")"

Phrase: "and to tau protein"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   819 E C1421563:protein tau [Gene or Genome]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1515981:And [Idea or Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "the principal constituent of NFTs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]
Processing 00000000.tx.24: ApoE was originally identified as a 37 kDa protein associated with regenerating nerves (18), and better defined in later studies on crushed sciatic nerves (1921) and lesioned brain (22,23). 

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "originally"

Phrase: "identified as a 37 kDa protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205396:Identified [Qualitative Concept]
   753   C1532717:kDa [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "associated with regenerating nerves"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0027740:Nerves [Tissue]
   770   C0334213:regenerating [Functional Concept]
   737 E C0027757:NERVE [Tissue]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "better defined in later studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C0442825:Well defined [Qualitative Concept]
   760   C0332272:Better [Qualitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726 E C0205170:Well [Qualitative Concept]
   726 E C3146287:Well [Manufactured Object]

Phrase: "on crushed sciatic nerves"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   901   C0036394:Sciatic Nerves [Body Part, Organ, or Organ Component]
   896   C0273482:Crushed nerve [Injury or Poisoning]
   880 E C0027745:crush nerve [Therapeutic or Preventive Procedure]
   867 E C1278851:Sciatic nerve [Body Part, Organ, or Organ Component]
   827   C0027740:Nerves [Tissue]
   793 E C0027757:NERVE [Tissue]
   793 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   755 E C0599851:Neural [Functional Concept]
   743 E C0027769:nervy [Sign or Symptom]

Phrase: "(1921"

Phrase: ")"

Phrase: "and"

Phrase: "lesioned brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.25: Following brain injury, synthesis of apoE by astrocytes is upregulated, and it is considered to play important roles in the mobilization and redistribution of cholesterol and phospholipids during membrane remodeling (24). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "brain injury,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0270611:Brain Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "synthesis of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "by astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "is"

Phrase: "upregulated"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "important roles in the mobilization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "redistribution of cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332620:Redistribution [Functional Concept]

Phrase: "and"

Phrase: "phospholipids during membrane remodeling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   737 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.26: Under these conditions of increased cholesterol availability, cholesterol synthesis is repressed both in the peripheral nerve (25) and the brain (23). 

Phrase: "Under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of increased cholesterol availability,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0470187:Availability [Functional Concept]
   734   C3276464:Increased cholesterol [Finding]

Phrase: "cholesterol synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599474:cholesterol synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "repressed"

Phrase: "both in the peripheral nerve"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0031119:Peripheral nerve [Body Part, Organ, or Organ Component]
   806   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]
   760   C0027740:Nerve [Tissue]
   760   C0027757:NERVE [Tissue]
   760   C0205100:Peripheral [Spatial Concept]
   760   C0238767:Both [Spatial Concept]
   760   C1280541:Nerve [Body Part, Organ, or Organ Component]
   760   C1706086:Both [Qualitative Concept]
   704 E C0599851:Neural [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.27: The cholesterol content of the brain decreases with age (26), and even further in AD (27). 

Phrase: "The cholesterol content of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "decreases with age (26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Age [Organism Attribute]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "even further in AD"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.28: Recent studies with cultured cells implicate cholesterol-rich membrane microdomains in processing of the amyloid precursor protein (APP) (see below). 

Phrase: "Recent studies with cultured cells"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   811   C0681854:culture cell study [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "implicate"

Phrase: "cholesterol-rich membrane microdomains in processing of the amyloid precursor protein (APP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0887868:Membrane Microdomains [Cell Component]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.29: Interestingly, a recent work showed that apoE4 induces neuronal cell death under conditions of suppressed cholesterol synthesis (28), suggesting that apoE4 may possibly be less efficient than apoE3 in reparative function in the brain under compromised cholesterol supply. 

Phrase: "Interestingly,"

Phrase: "a recent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neuronal cell death under conditions of suppressed cholesterol synthesis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C2754100:neuronal cell death [Cell Function]
           neuron death
   764   C0007587:Cell Death [Cell Function]
   742   C0007634:Cell [Cell]
   742   C0011065:Death [Organism Function]
   742   C1269647:Cell [Cell]
   742   C1306577:Death, NOS [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   726   C2936320:Synthetic Cell [Manufactured Object]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "may"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "be"

Phrase: "less efficient than apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442799:Efficient [Qualitative Concept]

Phrase: "in reparative function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "under compromised cholesterol supply."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243163:supply [Idea or Concept]
   827   C0699914:supply [Quantitative Concept]
   827   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   827   C1561604:supply [Functional Concept]
   827   C1875802:SUPPLY [Medical Device]
   827   C1999230:Supply [Activity]
Processing 00000000.tx.30: Thus, cholesterol is an intriguing possible link between apoE and AD etiology. 

Phrase: "Thus,"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "is"

Phrase: "an intriguing possible link between apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "AD etiology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1314792:disease etiology [Functional Concept]
           Aetiology
   827   C0015127:aetiology [Functional Concept]
   827   C1524003:Etiology [Conceptual Entity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]
Processing 00000000.tx.31: When allele-specific differences in apoE function need to be identified in vivo, it is desirable to have mouse lines in which the murine apoE is replaced by human apoE isoforms expressed under the natural regulation of this protein. 

Phrase: "When"

Phrase: "allele-specific differences in apoE function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "it"

Phrase: "is"

Phrase: "desirable to"

Phrase: "have"

Phrase: "mouse lines in which"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "the murine apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "replaced by human apoE isoforms"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   816   C0443526:Apolipoprotein E isoform [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1299987:Replaced by [Functional Concept]
           replaced
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086418:Human [Human]
   753   C0559956:Replaced [Functional Concept]
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "expressed under the natural regulation of this protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205296:Natural [Functional Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.32: Thus, Sullivan et al. 

Phrase: "Thus,"

Phrase: "Sullivan et al."
Processing 00000000.tx.33: (29,30) produced human apoE3 and apoE2 knock-in mouse lines, and most recently succeeded in apoE4 mice (31). 

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: "produced human apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "apoE2 knock-in mouse lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "most recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "succeeded in apoE4 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   770   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.34: The E4 homozygotes were found to have plasma cholesterol levels similar to the E3 mice, whereas E2 mice exhibited hypercholesterolemia. 

Phrase: "The E4 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "plasma cholesterol levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   901   C0858034:plasma cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "similar to the E3 mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "whereas"

Phrase: "E2 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "hypercholesterolemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020443:Hypercholesterolaemia [Disease or Syndrome]
  1000   C1522133:Hypercholesterolemia [Finding]
Processing 00000000.tx.35: We independently undertook generation of human apoE knock-in mice, using a different construct design of targeting vector. 

Phrase: "We independently"

Phrase: "undertook"

Phrase: "generation of human apoE knock-in mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a different construct design of targeting vector."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1707689:Design [Activity]
   748   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.36: Our E4 homozygous mice exhibit an elevated serum cholesterol level compared with the wild-type mice, whereas brain cholesterol content was significantly decreased. 

Phrase: "Our E4 homozygous mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an elevated serum cholesterol level"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   923   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   923   C0595929:ELEVATED SERUM CHOLESTEROL [Finding]
   923   C1287371:Serum cholesterol level [Laboratory or Test Result]
   875   C0020443:Elevated Cholesterol [Disease or Syndrome]
   861   C0201950:cholesterol level [Laboratory Procedure]
   861   C0428466:Cholesterol level [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0229671:Serum [Body Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1546774:Serum [Intellectual Product]
   812   C1547707:Level [Geographic Area]
   812   C1550100:Serum [Body Substance]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "compared with the wild-type mice,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C1520150:Wild Type Mouse [Mammal]
   790   C1883559:Wild Type [Organism Attribute]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "whereas"

Phrase: "brain cholesterol content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.37: This suggests that our human apoE4 knock-in mice will provide useful animal models for AD research in relation to cholesterol and lipid metabolism.  

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "our human apoE4 knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1517676:Knock-in [Research Activity]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "will"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "useful animal models for AD research"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0012644:Animal Disease Models [Experimental Model of Disease]
   789   C0599779:Research Model, Animal [Animal]
           Models, Animal
   774   C0003047:animal disease [Disease or Syndrome]
   774   C0003048:Animal Research [Research Activity]
   774   C0683033:disease models [Intellectual Product]
   774   C0684309:disease models [Experimental Model of Disease]
   774   C0699956:models research [Intellectual Product]
   748   C0003062:Animal [Animal]
   748   C3161035:Models [Intellectual Product]

Phrase: "in relation to cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "lipid metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.38: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Generation of human apoE4 knock-in mice The knock-in gene-targeting vector was designed to replace all of the mouse Apoe coding sequences including part of exon 2, entire exon 3 and most of exon 4, with the human apoE4 cDNA (Fig. 1A). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of human apoE4 knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "The knock-in gene-targeting vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "all of the mouse Apoe coding sequences"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0009219:Coding [Occupational Activity]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0444868:All [Quantitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C3539085:All [Idea or Concept]
   745   C0079941:Coding Sequence [Gene or Genome]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C0805701:Code [Intellectual Product]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "part of exon 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "entire exon 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0439751:Entire [Quantitative Concept]
   827   C0444667:Entire [Quantitative Concept]

Phrase: "and"

Phrase: "most of exon 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205393:Most [Quantitative Concept]

Phrase: "with the human apoE4 cDNA (Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.39: To retain normal mouse Apoe regulatory sequences as much as possible, the translation initiation codon of the human apoE4 cDNA in the knock-in allele was placed at the same position as that of the mouse Apoe in the wild-type locus. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "normal mouse Apoe regulatory sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   806   C0314642:Regulatory sequence [Nucleotide Sequence]
   804   C0162326:Sequences [Nucleotide Sequence]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "as"

Phrase: "much as possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332149:Possible [Qualitative Concept]
   790   C1705910:Possible [Qualitative Concept]
   790   C2362652:Possible [Qualitative Concept]

Phrase: "the translation initiation codon of the human apoE4 cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0242610:Codon, Initiation [Nucleotide Sequence]
   742   C0009221:Codon [Nucleotide Sequence]
   742   C1095825:Codon [Plant]

Phrase: "in the knock-in allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1517676:Knock-in [Research Activity]

Phrase: "was"

Phrase: "placed at the same position"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0445247:Same [Qualitative Concept]
   760   C0733755:Position [Spatial Concept]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "as that"

Phrase: "of the mouse Apoe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "in the wild-type locus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708726:Locus [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.40: Thus, non-coding mouse sequences including exon 1, intron 1 and the first 18 bp of exon 2 were retained in the knock-in allele (see Materials and Methods). 

Phrase: "Thus,"

Phrase: "non-coding mouse sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   858   C0079941:Coding Sequence [Gene or Genome]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]
   708   C1513853:NON Mouse [Mammal]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exon 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the first 18 bp of exon 2"

Phrase: "were"

Phrase: "retained in the knock-in allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1517676:Knock-in [Research Activity]
   753   C0002085:Allele [Gene or Genome]
   753   C0333118:Retained [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.41: View larger version (18K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.42: Targeting strategy for apoE4 knock-in mice and homologous intergration of the transgene. 

Phrase: "Targeting strategy for apoE4 knock-in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679199:strategy [Mental Process]

Phrase: "and"

Phrase: "homologous intergration of the transgene."
Processing 00000000.tx.43: (A) Schematic diagram of the knock-in targeting strategy. 

Phrase: "(A) Schematic diagram of the knock-in targeting strategy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681494:Diagram [Intellectual Product]
Processing 00000000.tx.44: (Top) The structure of the endogenous Apoe locus including exons 14 (black boxes). 

Phrase: "(Top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "The structure of the endogenous Apoe locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exons 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(black boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: ")."
Processing 00000000.tx.45: (Middle) The targeting vector containing the human apoE4 cDNA (hu cDNA). 

Phrase: "(Middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: ")"

Phrase: "The targeting vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the human apoE4 cDNA (hu cDNA"

Phrase: ")."
Processing 00000000.tx.46: (Bottom) The predicted structure of the knock-in allele after homologous recombination. 

Phrase: "(Bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "The predicted structure of the knock-in allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]

Phrase: "after homologous recombination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599773:Homologous Recombination [Genetic Function]
  1000   C2984295:Homologous recombination [Functional Concept]
   861   C0034865:Recombination [Genetic Function]
   861   C1334043:Homologous [Gene or Genome]
Processing 00000000.tx.47: The neomycin-resistance (neo) and thymidine kinase (TK) genes are for selection of the targeted ES cells. 

Phrase: "The neomycin-resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(neo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "and"

Phrase: "thymidine kinase (TK) genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1336633:Thymidine Kinase Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   734   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are for selection of the targeted ES cells."
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   790   C0596508:Embryonic Stem Cells [Cell]
   764   C0038250:Stem cells [Cell]
   745   C0221284:Target cells [Cell]
   745   C1947950:Embryonic Cell [Embryonic Structure]
   745   C3272919:Target Cells [Laboratory Procedure]
   742   C0007634:Cells [Cell]
   742   C0013935:Embryonic [Embryonic Structure]
   742   C0036576:selection [Genetic Function]
   742   C0242767:Stem [Plant]
   742   C1186763:Stem [Body Part, Organ, or Organ Component]
   742   C1521840:Targeted [Functional Concept]
   742   C1551058:Are [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.48: The neo cassette is flanked by 34 bp loxP sequences (triangles). 

Phrase: "The neo cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450240:Cassette [Medical Device]
   861   C1706210:Cassette [Manufactured Object]

Phrase: "is"

Phrase: "flanked by 34 bp loxP sequences"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719   C0230171:Flank [Body Location or Region]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.49: pA represents the endogenous polyadenylation signals. 

Phrase: "pA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the endogenous polyadenylation signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.50: Restriction sites: B, BglII; 

Phrase: "Restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   966   C1882940:Restriction Site [Nucleotide Sequence]
   861   C0205145:Sites [Spatial Concept]
   861   C0443288:Restriction [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "BglII"

Phrase: ";"
Processing 00000000.tx.51: E, EcoRI; 

Phrase: "E,"

Phrase: "EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.52: H, HindIII; 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "HindIII"

Phrase: ";"
Processing 00000000.tx.53: N, NcoI; 

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "NcoI"

Phrase: ";"
Processing 00000000.tx.54: S, SalI; 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "SalI"

Phrase: ";"
Processing 00000000.tx.55: X, XmnI. 

Phrase: "X,"

Phrase: "XmnI."
Processing 00000000.tx.56: (B) Southern blot analysis of tail-tip DNA from wild-type (+/+), heterozygous (4/+) and homozygous (4/4) knock-in mice digested with HindIII and hybridized with the 3' probe shown in (A). 

Phrase: "(B) Southern blot analysis of tail-tip DNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   800   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   767   C0200898:DNA analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1710133:Southern [Spatial Concept]

Phrase: "from wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(+/+"

Phrase: ")"

Phrase: ","

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "(4/+"

Phrase: ")"

Phrase: "and"

Phrase: "homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "(4/4"

Phrase: ")"

Phrase: "knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "hybridized with the 3' probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0182400:Probe [Medical Device]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in (A"

Phrase: ")."
Processing 00000000.tx.57: The wild-type Apoe allele generates an 8.0 kb HindIII fragment, whereas the targeted allele yields the diagnostic 6.4 kb HindIII fragment.  

Phrase: "The wild-type Apoe allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "generates"

Phrase: "an 8.0 kb HindIII fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "whereas"

Phrase: "the targeted allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "yields"

Phrase: "the diagnostic 6.4 kb HindIII fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.58: The knock-in construct was introduced into E14TG2aIV embryonic stem (ES) cells (32) by electroporation, and cell clones were selected by growth in media containing G418/gancyclovir. 

Phrase: "The knock-in construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827421:Construct [Classification]
   734   C1517676:Knock-in [Research Activity]

Phrase: "was"

Phrase: "introduced into E14TG2aIV embryonic stem (ES) cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0596508:Embryonic Stem Cells [Cell]
   790   C0038250:Stem cells [Cell]
   767   C1947950:Embryonic Cell [Embryonic Structure]
   753   C0007634:Cells [Cell]
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0242767:Stem [Plant]
   753   C1186763:Stem [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1292748:introduce [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "by electroporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206691:Electroporation [Laboratory Procedure,Research Activity]

Phrase: "and"

Phrase: "cell clones"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0009013:cell clones [Cell]
           Clones
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "selected by growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]
   756   C1707391:Select [Activity]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "G418/gancyclovir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017066:Gancyclovir [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.59: Drug-resistant ES clones were screened for homologous recombination by Southern blot hybridization using 3' flanking sequences outside the gene-targeting vector, exon 4 or neo probes (data not shown). 

Phrase: "Drug-resistant ES clones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0009013:Clones [Cell]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "were"

Phrase: "screened for homologous recombination"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0599773:Homologous Recombination [Genetic Function]
   833   C2984295:Homologous recombination [Functional Concept]
   770   C0034865:Recombination [Genetic Function]
   770   C1334043:Homologous [Gene or Genome]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "by Southern blot hybridization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0005862:Southern Blot Hybridization [Molecular Biology Research Technique]
           Southern Blot
   913   C0599927:southern hybridization [Laboratory Procedure,Molecular Biology Research Technique]
   901   C1148472:Blot, Southern [Laboratory or Test Result]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]
   827   C1710133:Southern [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3' flanking sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
  1000   C0949648:Sequences, 3' Flanking [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   884   C1883633:3' Flank [Nucleotide Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0230171:flanking [Body Location or Region]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the gene-targeting vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
   734   C0242613:Gene Targeting [Molecular Biology Research Technique]

Phrase: "exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "neo probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.60: We identified 7 of 125 G418/gancyclovir-resistant ES clones as having the correct insertion, and two clones (#129 and #145) were used for further studies. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "7 of 125 G418/gancyclovir-resistant ES clones"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0009013:Clones [Cell]
   742   C0013935:Embryonic [Embryonic Structure]
   742   C0017066:Gancyclovir [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   742   C0052009:G418 [Antibiotic,Organic Chemical]
   742   C0242767:Stem [Plant]
   742   C0332325:Resistant [Functional Concept]
   742   C1186763:Stem [Body Part, Organ, or Organ Component]
   742   C2827757:RESISTANT [Laboratory or Test Result]
   708 E C1522642:Clone [Tissue]

Phrase: "as"

Phrase: "having"

Phrase: "the correct insertion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "and"

Phrase: "two clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(#129"

Phrase: "and #"

Phrase: "145"

Phrase: ")"

Phrase: "were"

Phrase: "used for further studies."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1517331:Further [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0205108:far [Spatial Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.61: In these knock-in ES cells, human apoE immunoreactivity could be demonstrated by western blotting the cell lysates with monoclonal antibody (mAb) 868E5 (see below), whereas mouse apoE was detected both in wild-type and knock-in ES cells with mAb 874B7 (data not shown). 

Phrase: "In these knock-in ES cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0596508:Embryonic Stem Cells [Cell]
   840   C0038250:Stem cells [Cell]
   836   C1947950:Embryonic Cell [Embryonic Structure]
   804   C0007634:Cells [Cell]
   804   C0013935:Embryonic [Embryonic Structure]
   804   C0242767:Stem [Plant]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "human apoE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597879:immunoreactivity [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "demonstrated by western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "the cell lysates with monoclonal antibody (mAb) 868E5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "mouse apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "both in wild-type"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0238767:Both [Spatial Concept]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "knock-in ES cells with mAb 874B7"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0596508:Embryonic Stem Cells [Cell]
   764   C0038250:Stem cells [Cell]
   745   C1947950:Embryonic Cell [Embryonic Structure]
   742   C0007634:Cells [Cell]
   742   C0013935:Embryonic [Embryonic Structure]
   742   C0242767:Stem [Plant]
   742   C1186763:Stem [Body Part, Organ, or Organ Component]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.62: The two independently targeted ES cell clones were injected into C57BL/6N blastocysts, and chimeric mice were generated. 

Phrase: "The two independently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "ES cell clones"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0009013:cell clones [Cell]
           Clones
   779 E C1522642:Clone [Tissue]
   756   C0596508:Embryonic stem cell [Cell]
   729 E C1704387:Clonal [Qualitative Concept]
   708   C1947950:Embryonic Cell [Embryonic Structure]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "injected into C57BL/6N blastocysts,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C1511382:C57BL/6N [Mammal]
   760   C0025921:C57BL [Mammal]
   760   C1281743:Blastocysts [Embryonic Structure]
   726 E C0005705:Blastocyst [Embryonic Structure]
   726 E C1281786:Blastocyst [Embryonic Structure]
   726   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "chimeric mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "generated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]
Processing 00000000.tx.63: Male chimeric mice were mated with C57BL/6N females to produce heterozygous (4/+) mice. 

Phrase: "Male chimeric mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "mated with C57BL/6N females to"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C1511382:C57BL/6N [Mammal]
   753   C0015780:Females [Finding]
   753   C0025921:C57BL [Mammal]
   753   C0086287:Females [Population Group]
   753   C1254211:mated [Pharmacologic Substance]
   753   C1260875:Mated [Organism Function]
   719 E C0043210:female [Population Group]
   719 E C0682323:mate [Family Group]
   719 E C1705497:Female [Qualitative Concept]
   719 E C1705498:Female [Qualitative Concept]

Phrase: "produce"

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "(4/+"

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.64: The knock-in allele was transmitted to four of seven agouti coat color offspring derived from the #129 ES cell clone (data not shown). 

Phrase: "The knock-in allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1517676:Knock-in [Research Activity]

Phrase: "was"

Phrase: "transmitted to four of seven agouti"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205450:Four [Quantitative Concept]
   753   C0205453:Seven [Quantitative Concept]
   753   C0242781:Transmitted [Pathologic Function]
   753   C0332289:transmitted [Functional Concept]
   753   C1265498:Agouti [Mammal]
   753   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "coat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0453946:Coat [Manufactured Object]
  1000   C1522408:Coat [Qualitative Concept]
  1000   C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "color offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "derived from the #129 ES cell clone"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0596508:Embryonic stem cell [Cell]
   770   C0009013:Cell Clone [Cell]
           Clone
   770   C0038250:Stem cell [Cell]
   767   C1947950:Embryonic Cell [Embryonic Structure]
   744   C0007634:Cell [Cell]
   744   C0013935:Embryonic [Embryonic Structure]
   744   C0242767:Stem [Plant]
   744   C1186763:Stem [Body Part, Organ, or Organ Component]
   744   C1269647:Cell [Cell]
   744   C1441547:Derived [Qualitative Concept]
   744   C1522642:Clone [Tissue]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3245521:derived [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.65: The heterozygous (4/+) mice in the F2 generation were crossed, and produced litters of normal size with a normal Mendelian segregation pattern of the knock-in allele. 

Phrase: "The heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "(4/+"

Phrase: ")"

Phrase: "mice in the F2 generation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "crossed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205203:Crossed [Spatial Concept]
   966 E C2828360:Cross [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "produced litters of normal size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0023881:Litter Size [Quantitative Concept]
   760   C1299950:Litter [Manufactured Object]

Phrase: "with a normal Mendelian segregation pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Pattern [Spatial Concept]

Phrase: "of the knock-in allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1517676:Knock-in [Research Activity]
Processing 00000000.tx.66: Genotypes of F3 generation mice were determined using Southern blot analysis of tail-tip DNA digested with HindIII (Fig. 1B). 

Phrase: "Genotypes of F3 generation mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Southern blot analysis of tail-tip DNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   814   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   774   C0200898:DNA analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1710133:Southern [Spatial Concept]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: The results reported here were obtained with F3 generation animals of mouse line TgH(HAPE4)129. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "were"

Phrase: "obtained with F3 generation animals of mouse line TgH"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   742   C0003062:Animals [Animal]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0079411:Generation [Temporal Concept]
   742   C0205132:Line [Spatial Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1413347:TGH [Gene or Genome]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C3146294:Generation [Activity]
   708 E C1706701:Obtain [Activity]

Phrase: "(HAPE4"

Phrase: ")"

Phrase: "129."
Processing 00000000.tx.68: The amino acid sequence of the entire transgene product was confirmed to be that of the correct human apoE4 (33,34) by cDNA cloning and sequencing of human apoE mRNA from the liver of a transgenic mouse of this line. 

Phrase: "The amino acid sequence of the entire transgene product"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0202406:Acid [Laboratory Procedure]
   742   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "that of the correct human apoE4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   753   C0086418:Human [Human]
   753   C2349182:Correct [Qualitative Concept]
   753   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: "by cDNA cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "sequencing of human apoE mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]

Phrase: "from the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "of a transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "of this line."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.69: Expression of human apoE4 from the knock-in allele To examine the expression of human apoE4 from the knock-in allele, sera from the 4/4, 4/+ and +/+ mice were analyzed by western blot analysis (Fig. 2A). 

Phrase: "Expression of human apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from the knock-in allele To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "examine"

Phrase: "the expression of human apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from the knock-in allele,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1517676:Knock-in [Research Activity]

Phrase: "sera from the 4/4,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0229671:Sera [Body Substance]
   760   C1151254:SerA [Molecular Function]
   726 E C1546774:Serum [Intellectual Product]
   726 E C1550100:Serum [Body Substance]

Phrase: "4/+"

Phrase: "and +/+"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "analyzed by western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
           Analyzed
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.70: Human apoE4 protein was detected with human apoE-specific rat mAb 868E5 (35) in sera of the 4/4 and 4/+ mice at the same 37 kDa position as in a control human serum (Fig. 2A, upper panel). 

Phrase: "Human apoE4 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected with human apoE-specific rat mAb 868E5"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0313106:antibody e [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0947659:antibody e [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0086418:Human [Human]
   739   C0205369:Specific [Qualitative Concept]
   739   C0442726:Detected [Finding]
   739   C0746619:monoclonal [Finding]
   739   C1511790:Detected [Therapeutic or Preventive Procedure]
   739   C1552740:specific [Intellectual Product]

Phrase: "(35"

Phrase: ")"

Phrase: "in sera"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0229671:Sera [Body Substance]
  1000   C1151254:SerA [Molecular Function]
   966 E C1546774:Serum [Intellectual Product]
   966 E C1550100:Serum [Body Substance]

Phrase: "of the 4/4"

Phrase: "and"

Phrase: "4/+ mice at the same 37 kDa position"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "as in a control human serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0086418:Human [Human]
   753   C0229671:Serum [Body Substance]
   753   C0243148:control [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 2A,"

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.71: Western blot analysis with mouse apoE-specific hamster mAb 874B7 (35) showed that mouse apoE was present only in the 4/+ and +/+ and not in the 4/4 mice (Fig. 2A, lower panel), indicating that the mouse Apoe coding sequence was completely replaced in the 4/4 mice. 

Phrase: "Western blot analysis with mouse apoE-specific hamster mAb 874B7"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   753   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]
   736   C1705493:Western [Spatial Concept]

Phrase: "(35"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that mouse apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in the 4/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "and +/+"

Phrase: "and"

Phrase: "not in the 4/4 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1518422:Not [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the mouse Apoe coding sequence"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0079941:Coding Sequence [Gene or Genome]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0009219:Coding [Occupational Activity]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   779 E C0805701:Code [Intellectual Product]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "replaced in the 4/4 mice."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0559956:Replaced [Functional Concept]
   753   C1299987:replaced [Functional Concept]
   719 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.72: Although we cannot precisely compare the amount of human and mouse apoE proteins on western blots due to the likely difference in the affinity of antibodies, it seemed that the level of human apoE4 in the serum of the 4/4 mice was comparable to that of mouse apoE in the wild-type mice. 

Phrase: "Although"

Phrase: "we"

Phrase: "cannot"

Phrase: "precisely"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the amount of human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "mouse apoE proteins on western blots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "due to the likely difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "in the affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "of antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "it"

Phrase: "seemed"

Phrase: "that"

Phrase: "the level of human apoE4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "of the 4/4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "comparable to that of mouse apoE"

Phrase: "in the wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.73: We further showed that apoE in the knock-in mice was recognized by anti-apoE4 specific antibody Ab 412-1-12-2 which binds an apoE4-specific epitope (36) (Fig. 2B). 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that apoE in the knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "recognized"

Phrase: "by anti-apoE4 specific antibody Ab 412-1-12-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   829   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   807   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   791   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   791   C0205369:Specific [Qualitative Concept]
   791   C1552740:specific [Intellectual Product]
   791   C2984964:APOE4 [Laboratory Procedure]

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "an apoE4-specific epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitope [Immunologic Factor]

Phrase: "(36"

Phrase: ")"

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.74: View larger version (30K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.75: Correct expression of apoE4 transgene production in the serum and brain of knock-in mice. 

Phrase: "Correct expression of apoE4 transgene production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "brain of knock-in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.76: (A) Western blot of sera with species-specific anti-apoE antibodies. 

Phrase: "(A) Western blot of sera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]

Phrase: "with species-specific anti-apoE antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   859   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   841 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.77: (B) Sera from the +/+, 4/+ and 4/4 mice were analyzed with an anti-apoE4 isoform-specific antibody (36). 

Phrase: "(B) Sera from the +/+,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0229671:Sera [Body Substance]
   770   C1151254:SerA [Molecular Function]
   737 E C1546774:Serum [Intellectual Product]
   737 E C1550100:Serum [Body Substance]

Phrase: "4/+"

Phrase: "and"

Phrase: "4/4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "analyzed with an anti-apoE4 isoform-specific antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   744   C0205369:Specific [Qualitative Concept]
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   744   C0936012:Analyzed [Research Activity]
   744   C1552740:specific [Intellectual Product]
   744   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.78: The heavy bands above and below the apoE bands are due to serum Ig heavy and light chains, respectively, directly binding the secondary antibody. 

Phrase: "The heavy bands above"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0175723:Bands [Medical Device]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "and below the apoE bands"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0175723:Bands [Medical Device]
   753   C1515981:And [Idea or Concept]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "are due to serum Ig"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0229671:Serum [Body Substance]
   760   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1551058:Are [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]
   760   C3541296:IG [Idea or Concept]

Phrase: "heavy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439539:Heavy [Qualitative Concept]

Phrase: "and"

Phrase: "light chains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0337112:chains [Manufactured Object]
   861   C1306462:Light [Functional Concept]
   861   C1524075:Chains [Idea or Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "respectively,"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the secondary antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.79: (C) Western blot of brain homogenates with human apoE-specific antibody shows gene dosage-dependent expression of the transgene product. 

Phrase: "(C) Western blot of brain homogenates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "with human apoE-specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "gene dosage-dependent expression of the transgene product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.80: Bands at the top (asterisks) are non-specific signals due to ABC binding. 

Phrase: "Bands at the top (asterisks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: ")"

Phrase: "are"

Phrase: "non-specific signals due to ABC binding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.81: Molecular weights (in kDa) are indicated to the left.  

Phrase: "Molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "("

Phrase: "in kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.82: In these experiments the extent of sialylation of apoE, as estimated from the characteristic upper bands (5), seems to be less in the mouse than in the human (Fig. 2A). 

Phrase: "In these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the extent of sialylation of apoE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439792:Extent [Spatial Concept]

Phrase: "as"

Phrase: "estimated from the characteristic upper bands"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0175723:Bands [Medical Device]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1282910:Upper [Spatial Concept]
   753   C1521970:Characteristic [Qualitative Concept]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less in the mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0439092:less [Intellectual Product]
   770   C0547044:Less [Qualitative Concept]

Phrase: "than"

Phrase: "in the human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.83: The possibility that the sialylation of apoE is differently regulated in the two species remains to be studied. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "the sialylation of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0872366:sialylation [Phenomenon or Process]

Phrase: "is"

Phrase: "differently"

Phrase: "regulated in the two species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1705920:Species [Conceptual Entity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.84: We next examined the expression of human apoE4 in the brains of the knock-in mouse. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the expression of human apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of the knock-in mouse."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
Processing 00000000.tx.85: Western blotting experiments showed that the human apoE of 37 kDa was expressed in the 4/4 and 4/+ mouse brains (Fig. 2C). 

Phrase: "Western blotting experiments"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   717 E C0949466:Western Blot [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the human apoE of 37 kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed in the 4/4"

Phrase: "and"

Phrase: "4/+ mouse brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1521713:Mouse Brain [Tissue]
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.86: Histological pattern of apoE expression was then studied by immunohistochemistry on frozen sections of paraformaldehyde-fixed brains of the three genotypes (Fig. 3). 

Phrase: "Histological pattern of apoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "studied by immunohistochemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "on frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0016741:Frozen Sections [Tissue]
   966 E C0085188:Frozen Section [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of paraformaldehyde-fixed brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of the three genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.87: Human apoE was detected in the astrocytes and neuropil in the hippocampus (Fig. 3A) and neocortex of the 4/4 mice, where no immunoreactivity for mouse apoE was detectable (Fig. 3B). 

Phrase: "Human apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in the astrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0004112:Astrocytes [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "neuropil in the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0228081:Neuropil [Cell Component]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "and"

Phrase: "neocortex of the 4/4 mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "where"

Phrase: "no immunoreactivity for mouse apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detectable"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.88: No clear apoE immunoreactivity was seen over neuronal somata, although the fluorescence microscopy could not rule out a weak staining of neuronal processes in addition to astrocytic processes in the neuropil. 

Phrase: "No clear apoE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "seen over neuronal somata,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C2952302:Neuronal somata [Cell Component]
   770   C0205397:Seen [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   737 E C0042789:see [Organism Function]
   737   C0599444:soma [Cell Component]
   737   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   737 E C1947903:See [Activity]

Phrase: "although"

Phrase: "the fluorescence microscopy"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a weak staining of neuronal processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "in addition to astrocytic processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "in the neuropil."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0228081:Neuropil [Cell Component]
Processing 00000000.tx.89: This pattern of apoE staining was similar to the distribution of mouse apoE in the +/+ mouse brain (Fig. 3F). 

Phrase: "This pattern of apoE staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C0449778:Pattern of staining [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "similar to the distribution of mouse apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "in the +/+ mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 3F"

Phrase: ")."
Processing 00000000.tx.90: Heterozygous brains showed staining of both human and mouse apoEs with intermediate intensity (Fig. 3C and D). 

Phrase: "Heterozygous brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "staining of both human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "mouse apoEs with intermediate intensity"

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.91: Thus the expression of the human apoE protein in our knock-in mice is apparently under the endogenous regulatory control. 

Phrase: "Thus"

Phrase: "the expression of the human apoE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in our knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "apparently under the endogenous regulatory control."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205227:Endogenous [Functional Concept]
   753   C0220905:regulatory [Regulation or Law]
   753   C0243148:control [Qualitative Concept]
   753   C0750541:apparently [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1704735:Regulatory [Conceptual Entity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.92: View larger version (144K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(144K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.93: Correct histological expression of apoE in the brain shown by anti-human (A, C and E) or anti-mouse (B, D and F) apoE antibodies. 

Phrase: "Correct histological expression of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "shown by anti-human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   737   C1547282:Show [Intellectual Product]

Phrase: "(A,"

Phrase: "C"

Phrase: "and"

Phrase: "E)"

Phrase: "or"

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "F) apoE antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   886   C0370187:f Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.94: Hippocampal CA1 region of fixed cryostat sections from the 4/4 (A and B), 4/+ (C and D) and +/+ (E and F) mice are shown. 

Phrase: "Hippocampal CA1 region of fixed cryostat sections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0694598:CA1 Region, Hippocampal [Body Location or Region]
   774   C3496509:hippocampal region [Body Location or Region]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "from the 4/4"

Phrase: "(A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "4/+"

Phrase: "(C"

Phrase: "and"

Phrase: "D)"

Phrase: "and +/+ ("

Phrase: "E"

Phrase: "and"

Phrase: "F) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.95: Note the similar patterns of apoE distribution over astrocytes and neuropil between human apoE in the knock-in (A) and mouse apoE in the wild-type (F) mice, and also intermediate expression of both apoEs in the heterozygote (C and D). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the similar patterns of apoE distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0449775:distribution patterns [Spatial Concept]
   748   C0449774:Patterns [Spatial Concept]

Phrase: "over astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "neuropil between human apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0228081:Neuropil [Cell Component]

Phrase: "in the knock-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517676:Knock-in [Research Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "mouse apoE in the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(F) mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "also intermediate expression of both apoEs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the heterozygote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygote [Organism Attribute]

Phrase: "(C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.96: Bar in (E), 100 m.  

Phrase: "Bar in (E"

Phrase: ")"

Phrase: ","

Phrase: "100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.97: Lipid and lipoprotein phenotypes As an initial step in studying the functional impact of expression of human apoE protein, the levels of total cholesterol (TC) and triglycerides (TG) in the 4/4, 4/+, +/+ and apoE-deficient (/) (37) mice were analyzed in the sera obtained after a 6 h fast (Table 1). 

Phrase: "Lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "lipoprotein phenotypes As an initial step in studying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0031437:Phenotypes [Organism Attribute]
   711 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "the functional impact of expression of human apoE protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   775   C1436260:IMPACT protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1825598:IMPACT [Gene or Genome]

Phrase: "the levels of total cholesterol (TC)"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "triglycerides (TG) in the 4/4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041004:Triglycerides [Biologically Active Substance,Lipid]

Phrase: "4/+,"

Phrase: "+/+"

Phrase: "and"

Phrase: "apoE-deficient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011155:Deficient [Functional Concept]
   827   C1636779:% deficient [Quantitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(/"

Phrase: ")"

Phrase: "(37"

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "analyzed in the sera"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0229671:Sera [Body Substance]
   770   C0936012:Analyzed [Research Activity]
   770   C1151254:SerA [Molecular Function]
   737 E C1546774:Serum [Intellectual Product]
   737 E C1550100:Serum [Body Substance]

Phrase: "obtained after a 6 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0444953:H 6 [Intellectual Product]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015663:Fast [Finding]
  1000   C0456962:Fast [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: Serum TC level in the 4/4 mice (251  23 mg/dl) was 2.5-fold greater than that in the +/+ mice (101  8 mg/dl), but still much lower than in the / mice (697  60 mg/dl). 

Phrase: "Serum TC level in the 4/4 mice"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   818   C1445957:Serum total cholesterol level [Laboratory Procedure]
   784   C0587184:Serum cholesterol level [Laboratory Procedure]
           Cholesterol - serum
   784   C1287371:Serum cholesterol level [Laboratory or Test Result]
   764   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol level
   764   C0428466:Cholesterol level [Laboratory or Test Result]
   764   C0543421:Total cholesterol [Steroid]
   764   C1441420:Serum.total [Laboratory or Test Result]
   762   C0456950:Level 4 [Qualitative Concept]
   762 E C1442946:Cholesterol.total [Laboratory or Test Result]
   742   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   742   C0229671:Serum [Body Substance]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1546774:Serum [Intellectual Product]
   742   C1547707:Level [Geographic Area]
   742   C1550100:Serum [Body Substance]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "(251  23 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "dl)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642216:/dL [Quantitative Concept]

Phrase: "was"

Phrase: "2.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "in the +/+ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(101  8 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "still much lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "in the / mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(697  60 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.99: Males showed higher TC levels than females: 289 mg/dl versus 212 for 4/4 mice, and 115 versus 87 for +/+ mice (n = 3 each). 

Phrase: "Males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "higher TC levels than females"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol levels
   790   C0428466:cholesterol levels [Laboratory or Test Result]
   790   C0543421:Total cholesterol [Steroid]
   787   C1522133:high cholesterol level [Finding]
           high cholesterol
   783 E C1442946:Cholesterol.total [Laboratory or Test Result]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "289 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: "versus"

Phrase: "212 for 4/4 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "115"

Phrase: "versus"

Phrase: "87 for +/+ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "each"

Phrase: ")."
Processing 00000000.tx.100: In the 4/+ mice, serum TC levels were slightly lower than in the +/+ mice. 

Phrase: "In the 4/+ mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "serum TC levels"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   966   C1445957:Serum total cholesterol level [Laboratory Procedure]
   906   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   906   C1287371:Serum cholesterol level [Laboratory or Test Result]
   861   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol levels
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   861   C0543421:Total cholesterol [Steroid]
   861   C1441420:Serum.total [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0229671:Serum [Body Substance]
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "slightly lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "in the +/+ mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.101: There was no significant difference in TG levels among the 4/4, 4/+ and +/+ mice. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in TG levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "among the 4/4,"

Phrase: "4/+"

Phrase: "and +/+"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.102: Similar results have been obtained for another independent knock-in line TgH(HAPE4)145. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "obtained for another independent knock-in line TgH"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C1517676:Knock-in [Research Activity]
   744   C0085862:Independent [Idea or Concept]
   744   C0205132:Line [Spatial Concept]
   744   C1299583:Independent [Finding]
   744   C1301820:Obtained [Functional Concept]
   744   C1413347:TGH [Gene or Genome]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "(HAPE4"

Phrase: ")"

Phrase: "145."
Processing 00000000.tx.103: For this line TC was 234 mg/dl for 4/4 compared with 131 for +/+ (n = 5 each). 

Phrase: "For this line TC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0201950:Total Cholesterol [Laboratory Procedure]
   901   C0543421:Total cholesterol [Steroid]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "234 mg/dl for 4/4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439269:mg dl [Quantitative Concept]
   783 E C3463848:dl mg [Quantitative Concept]
   753   C3642216:/dL [Quantitative Concept]

Phrase: "compared with 131"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "for +/+"

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "each"

Phrase: ")."
Processing 00000000.tx.104: The nature of elevated serum TC levels was further studied by analyzing lipoprotein profiles by fast protein liquid chromatography (FPLC) fractionation. 

Phrase: "The nature of elevated serum TC levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studied by analyzing lipoprotein profiles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0557651:Study [Manufactured Object]
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
   726   C2603343:Study [Research Activity]

Phrase: "by fast protein liquid chromatography (FPLC) fractionation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0016640:fractionation [Laboratory Procedure]
   804   C0524811:fractionation [Therapeutic or Preventive Procedure]
   804   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   771   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]
Processing 00000000.tx.105: As shown in Figure 4A and B, the main cholesterol carrier in serum was HDL (fractions 1725) in the +/+ and 4/+ mice. 

Phrase: "As"

Phrase: "shown in Figure 4A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450373:4a [Intellectual Product]
   770   C1553636:4a [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the main cholesterol carrier in serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007294:Carrier [Finding]
   753   C0560175:Carrier [Finding]
   753   C1706209:Carrier [Medical Device]
   753   C3273162:Carrier [Intellectual Product]

Phrase: "was"

Phrase: "HDL"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "(fractions 1725"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "in the +/+"

Phrase: "and"

Phrase: "4/+ mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.106: In the 4/4 mice, however, 60% of TC was found in regions corresponding to the VLDL and LDL (fractions 116) (Fig. 4C). 

Phrase: "In the 4/4 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "however,"

Phrase: "60% of TC"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0201950:Total Cholesterol [Laboratory Procedure]
   833   C0543421:Total cholesterol [Steroid]
   819 E C1442946:Cholesterol.total [Laboratory or Test Result]
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "found in regions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0150312:Found [Quantitative Concept]
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   756 E C0243095:Find [Finding]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "corresponding to the VLDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0523560:VLDL [Laboratory Procedure]

Phrase: "and"

Phrase: "LDL (fractions 116"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.108: Serum cholesterol and triglyceride levels in the knock-in and control mice  View larger version (36K): [in this window] [in a new window]  Figure 4. 

Phrase: "Serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0587184:serum cholesterol [Laboratory Procedure]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "triglyceride levels in the knock-in"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0428475:levels triglyceride [Laboratory or Test Result]
   753   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.109: Distribution of cholesterol and apoE among lipoprotein fractions of the knock-in and control mice. 

Phrase: "Distribution of cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "apoE among lipoprotein fractions of the knock-in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0003591:Lipoprotein apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Apolipoprotein

Phrase: "and"

Phrase: "control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.110: Sera from +/+ (A), 4/+ (B) and 4/4 (C) mice were size-fractionated by FPLC. 

Phrase: "Sera from +/+"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0229671:Sera [Body Substance]
   833   C1151254:SerA [Molecular Function]
   799 E C1546774:Serum [Intellectual Product]
   799 E C1550100:Serum [Body Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "4/+"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "4/4"

Phrase: "(C) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "size-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "fractionated by FPLC."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]
   790   C0008565:Liquid Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0015663:Fast [Finding]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0302908:Liquid [Substance]
   753   C0456962:Fast [Qualitative Concept]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.111: Cholesterol values of the fractions as measured enzymatically are shown in the upper panels. 

Phrase: "Cholesterol values of the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "as"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "enzymatically"

Phrase: "are"

Phrase: "shown in the upper panels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441833:Panel [Idea or Concept]
   760   C1282910:Upper [Spatial Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.112: ApoE distribution profiles are shown in the lower panels as western blots of the corresponding fractions with mouse- or human-specific anti-apoE antibodies as indicated.  

Phrase: "ApoE distribution profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "are"

Phrase: "shown in the lower panels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Panel [Idea or Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C1999270:Panel [Intellectual Product]
   760   C2003888:Lower [Activity]
   760   C3537156:Panel [Manufactured Object]
   726   C1547282:Show [Intellectual Product]

Phrase: "as western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "of the corresponding fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "with mouse-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "human-specific anti-apoE antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   859   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   841 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.113: The distribution of apoE was analyzed by western blot analysis of the FPLC fractions (Fig. 4, lower panels). 

Phrase: "The distribution of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "analyzed by western blot analysis of the FPLC fractions"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   800   C2121086:protein analysis by Western blot [Laboratory Procedure]
   790   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]
   770   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   753   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0008565:Liquid Chromatography [Laboratory Procedure]
   751   C1514534:Protein Analysis [Molecular Biology Research Technique]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0008550:Chromatography [Laboratory Procedure]
   736   C0015663:Fast [Finding]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0302908:Liquid [Substance]
   736   C0456962:Fast [Qualitative Concept]
   736   C0936012:Analysis [Research Activity]
           Analyzed
   736   C1264633:Fractions [Quantitative Concept]
           Fraction of
   736   C1304698:Liquid [Finding]
   736   C1524024:analysis [Functional Concept]
   736   C1546699:Liquid NOS [Intellectual Product]
   736   C1561501:Liquid NOS [Substance]
   736   C1705493:Western [Spatial Concept]
   703 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.114: In the +/+ and 4/+ mice, the mouse apoE was mostly found in the HDL (fractions 1725) and also LDL (fractions 1016) regions with only a minor portion showing up in the VLDL region (fractions 6 and 7). 

Phrase: "In the +/+"

Phrase: "and"

Phrase: "4/+ mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "the mouse apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "found in the HDL"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0150312:Found [Quantitative Concept]
   753   C0178587:density [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0243095:Find [Finding]

Phrase: "(fractions 1725"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "also LDL (fractions 1016"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "regions with only"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "a minor portion showing up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]

Phrase: "in the VLDL region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(fractions 6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.115: The distribution pattern of human apoE4 in the 4/+ mice was very similar to that of mouse apoE in the +/+ and 4/+ mice. 

Phrase: "The distribution pattern of human apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449775:Distribution pattern [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "in the 4/+ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "very similar to that of mouse apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "in the +/+"

Phrase: "and"

Phrase: "4/+ mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.116: In contrast, the majority of apoE was present in the VLDL and LDL regions with two peaks at fractions 67 and 1213 in the 4/4 mice, in addition to the presence in the HDL region. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the majority of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "was"

Phrase: "present in the VLDL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "LDL regions with two peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "at fractions 67"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "1213 in the 4/4 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "in addition to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "in the HDL region."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   756   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.117: On western blot analysis with anti-mouse apoE, three discrete bands of 34, 36 and 39 kDa were detected. 

Phrase: "On western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "with anti-mouse apoE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0313106:Anti e [Amino Acid, Peptide, or Protein,Immunologic Factor]
   902   C0947659:Anti E [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "three discrete bands of 34,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "36"

Phrase: "and"

Phrase: "39 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.118: The relative abundance of the three molecular species appeared to vary with fractions: the 39 kDa species was relatively more abundant in the VLDL, the 36 kDa species in the LDL and the 34 kDa species in the HDL regions. 

Phrase: "The relative abundance of the three molecular species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346714:Abundance [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "vary with fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1264633:Fractions [Quantitative Concept]
   756 E C1554103:Fraction [Idea or Concept]

Phrase: ":"

Phrase: "the 39 kDa species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "was"

Phrase: "relatively more abundant in the VLDL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundant [Qualitative Concept]

Phrase: "the 36 kDa species in the LDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "the 34 kDa species in the HDL regions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.119: With the anti-human apoE antibody, all fractions displayed the 37 kDa band accompanied by a weak low molecular weight band, a likely partial degradation fragment (38) (Fig. 4B and C). 

Phrase: "With the anti-human apoE antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   708   C0313106:Anti e [Amino Acid, Peptide, or Protein,Immunologic Factor]
   708   C0947659:Anti E [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "all fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the 37 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "accompanied by a weak low molecular weight band,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0026385:Molecular Weight [Quantitative Concept]
   767   C0041667:Low weight [Finding]
   744   C0004093:Weak [Sign or Symptom]
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C0175723:Band [Medical Device]
   744   C0205251:low [Qualitative Concept]
   744   C0439645:Band [Spatial Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1521913:band [Cell Component]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1550472:low [Idea or Concept]
   744   C1705104:Weight [Idea or Concept]
   744   C1762617:Weak [Qualitative Concept]

Phrase: "a likely partial degradation fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(38"

Phrase: ")"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.120: As the serum cholesterol level was markedly elevated in the 4/4 knock-in mice, it was of particular interest to examine the brain lipids. 

Phrase: "As the serum cholesterol level"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
  1000   C1287371:Serum cholesterol level [Laboratory or Test Result]
   901   C0201950:cholesterol level [Laboratory Procedure]
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1546774:Serum [Intellectual Product]
   827   C1547707:Level [Geographic Area]
   827   C1550100:Serum [Body Substance]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "elevated in the 4/4 knock-in mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1517676:Knock-in [Research Activity]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0205250:Elevated [Qualitative Concept]
   744   C3163633:Elevated [Qualitative Concept]

Phrase: "it"

Phrase: "was of particular interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0543488:Interest [Mental Process]
   760   C1421478:WAS [Gene or Genome]

Phrase: "examine"

Phrase: "the brain lipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]
Processing 00000000.tx.121: The brain size was not significantly different among mice of 4/4, 4/+ and +/+ genotypes. 

Phrase: "The brain size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0870226:brain size [Quantitative Concept]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0456389:size [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "not significantly different among mice of 4/4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "4/+"

Phrase: "and +/+"

Phrase: "genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.122: Total cholesterol level of the whole brain, however, was reduced by >30% in the 4/4 brain compared with the +/+ brain (Table 2). 

Phrase: "Total cholesterol level of the whole brain,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol level
   778   C0428466:Cholesterol level [Laboratory or Test Result]
   778   C0543421:Total cholesterol [Steroid]
   774 E C1442946:Cholesterol.total [Laboratory or Test Result]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "however,"

Phrase: "was"

Phrase: "reduced by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0392756:Reduced [Qualitative Concept]

Phrase: ">30% in the 4/4 brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1418764:BRAIN-4 [Gene or Genome]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with the +/+ brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1707455:Compared [Activity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: A less pronounced reduction in TC was also observed in the brains of the heterozygotes. 

Phrase: "A less pronounced reduction in TC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "observed in the brains of the heterozygotes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0019425:Heterozygotes [Organism Attribute]
   748   C1441672:Observed [Functional Concept]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.124: A significant reduction in the brain phospholipid content was also found in the 4/4 mice, but not in the heterozygotes. 

Phrase: "A significant reduction in the brain phospholipid content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "found in the 4/4 mice,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0150312:Found [Quantitative Concept]
   719 E C0243095:Find [Finding]

Phrase: "but"

Phrase: "not in the heterozygotes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0019425:Heterozygotes [Organism Attribute]
   770   C1518422:Not [Functional Concept]
Processing 00000000.tx.125: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.126: Brain cholesterol and phospholipid levels in the knock-in and control mice  No difference in gross morphology of the brain was apparent among the 4/4, 4/+ and +/+ mice. 

Phrase: "Brain cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "phospholipid levels in the knock-in"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "No difference in gross morphology of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "apparent among the 4/4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "4/+"

Phrase: "and +/+"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.127: No significant difference was noted among the three genotypes in a preliminary histological survey, in which brain sections from 3-month-old mice were stained by thionin or by antibodies specific to GFAP (astrocyte marker), VAMP-2 (synapse marker) or mouse apoJ. 

Phrase: "No significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "noted among the three genotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017431:Genotypes [Organism Attribute]
   760   C0205449:Three [Quantitative Concept]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "in a preliminary histological survey,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038951:Survey [Intellectual Product]

Phrase: "in which brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "from 3-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "stained by thionin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0076494:Thionin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Thionin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or by antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific to GFAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(astrocyte marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "VAMP-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0148340:VAMP-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VAMP-2 [Gene or Genome]
   861   C0279853:VAMP [Therapeutic or Preventive Procedure]
   861   C0635146:VAMP [Therapeutic or Preventive Procedure]

Phrase: "(synapse marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "mouse apoJ."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0055966:Apo-J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1413514:APOJ [Gene or Genome]
   861   C2609437:APOJ [Laboratory Procedure]
   861   C2827446:APOJ [Gene or Genome]
Processing 00000000.tx.128: A more thorough study is needed to establish absence of altered anatomical phenotype in the knock-in brains.  

Phrase: "A more thorough study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "absence of altered anatomical phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the knock-in brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1517676:Knock-in [Research Activity]
Processing 00000000.tx.129: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We have produced a line of human apoE4 knock-in mice in which the expression of human apoE4 is under the control of the enhancer/promoter of endogenous mouse Apoe gene, and mouse apoE expression was completely eliminated. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "produced"

Phrase: "a line of human apoE4 knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C1522424:A Mouse [Mammal]
   744   C0205132:Line [Spatial Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]

Phrase: "in which"

Phrase: "the expression of human apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is under the control of the enhancer/promoter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "of endogenous mouse Apoe gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412481:APOE gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "mouse apoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "eliminated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]
Processing 00000000.tx.130: In these mice, serum cholesterol level was 2.5 times that of the +/+ littermate controls. 

Phrase: "In these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "serum cholesterol level"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
  1000   C1287371:Serum cholesterol level [Laboratory or Test Result]
   901   C0201950:cholesterol level [Laboratory Procedure]
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1546774:Serum [Intellectual Product]
   827   C1547707:Level [Geographic Area]
   827   C1550100:Serum [Body Substance]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "2.5 times"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "that of the +/+ littermate controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.131: This marked elevation of serum cholesterol was shown to be primarily due to an accumulation of very low and low density lipoproteins. 

Phrase: "This marked elevation of serum cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "primarily due to an accumulation of very low"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0442811:Very low [Finding]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0205251:low [Qualitative Concept]
   744   C0442824:Very [Qualitative Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1550472:low [Idea or Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "low density lipoproteins."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023823:Low-Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.132: The brains of 4/4 mice had significantly reduced total cholesterol and phospholipids compared with the littermate controls. 

Phrase: "The brains of 4/4 mice"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C1418764:BRAIN-4 [Gene or Genome]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   750   C1521713:Mouse Brain [Tissue]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "had"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "total cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0201950:Total Cholesterol [Laboratory Procedure]
  1000   C0543421:Total cholesterol [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "compared with the littermate controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.133: Transgenic mouse models A number of research groups have in the past produced mice expressing human apoE isoforms instead of the mouse protein through pronuclear injection of human apoE cDNAs placed under various heterologous promoters, and breeding with the apoE-deficient (knock-out) lines generated earlier to eliminate the mouse protein (3941). 

Phrase: "Transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "A number of research groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2985777:Group Number [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have in the past produced mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1444637:Past [Temporal Concept]
   753   C3154893:Have [Idea or Concept]
   753   C3539897:Have [Qualitative Concept]

Phrase: "expressing"

Phrase: "human apoE isoforms instead of the mouse protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C0443526:Apolipoprotein E isoform [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   762   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "through pronuclear injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of human apoE cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "placed under various heterologous promoters,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439860:Heterologous [Qualitative Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "breeding with the apoE-deficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006159:Breeding [Organism Function]

Phrase: "(knock-out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0560617:knock out [Injury or Poisoning]
  1000   C1522225:Knock-out [Experimental Model of Disease]
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: ")"

Phrase: "lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "earlier to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1279919:Early [Temporal Concept]

Phrase: "eliminate"

Phrase: "the mouse protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3941"

Phrase: ")."
Processing 00000000.tx.134: In this type of transgenic mouse generally, the levels and patterns of transgene expression vary from line to line due to differences in the chromosomal integration sites with unavoidable position effects as well as uncontrollable copy numbers of inserted transgenes. 

Phrase: "In this type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "of transgenic mouse generally,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mouse, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "patterns of transgene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "vary from line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205132:Line [Spatial Concept]
   790   C1550648:Line [Substance]
   790   C1552960:Line [Quantitative Concept]

Phrase: "to line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "due to differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in the chromosomal integration sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "with unavoidable position effects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0733755:Position [Spatial Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "as well as"

Phrase: "uncontrollable copy numbers of inserted transgenes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1707513:Copy Number [Quantitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C1948062:Copy [Manufactured Object]
Processing 00000000.tx.135: Thus, no two lines can be precisely matched for studying subtle isoform differences. 

Phrase: "Thus,"

Phrase: "no two lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "precisely"

Phrase: "matched for studying subtle isoform differences."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0150103:matched [Research Activity]
   753   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   753   C1708943:Matched [Qualitative Concept]
   719   C0557651:Study [Manufactured Object]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
   719   C2603343:Study [Research Activity]
Processing 00000000.tx.136: Moreover, expression of apoE in cell types other than the natural expressers through use of heterologous promoters may not provide a valid model animal for AD research. 

Phrase: "Moreover,"

Phrase: "expression of apoE in cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "other than the natural expressers"

Phrase: "through use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of heterologous promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a valid model animal for AD research."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C0012644:Disease Model, Animal [Experimental Model of Disease]
   789   C0599779:Research Model, Animal [Animal]
           Animal Model
   767   C0003047:animal disease [Disease or Syndrome]
   767   C0003048:Animal Research [Research Activity]
   744   C0003062:Animal [Animal]
Processing 00000000.tx.137: GFAP promoter has been used by some to direct expression of human apoE to astrocytes (39,40). 

Phrase: "GFAP promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "has"

Phrase: "been"

Phrase: "used by some to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C1273517:Used by [Finding]
           used
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "expression of human apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.138: However, the expression pattern of apoE in the normal mouse brain does not exactly coincide with that of GFAP (35). 

Phrase: "However,"

Phrase: "the expression pattern of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "in the normal mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1521713:Mouse Brain [Tissue]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "does"

Phrase: "not exactly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "coincide with that of GFAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1415042:GFAP [Gene or Genome]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.139: Expected absence of apoE in the periphery in such mice should cause disturbances in the systemic lipid metabolism (42,43) that may have indirect consequences in the central nervous system (CNS). 

Phrase: "Expected absence of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the periphery"

Phrase: "in such mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "should"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "disturbances in the systemic lipid metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2699787:Disturbance [Qualitative Concept]

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: "that"

Phrase: "may"

Phrase: "have"

Phrase: "indirect consequences in the central nervous system (CNS)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0686907:consequences [Functional Concept]
Processing 00000000.tx.140: A most desirable approach, therefore, is to place the transgene expression under the control of endogenous regulatory elements. 

Phrase: "A most desirable approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "therefore,"

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "the transgene expression under the control of endogenous regulatory elements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.141: Xu et al. 

Phrase: "Xu et al."
Processing 00000000.tx.142: (44) introduced large segments of human genomic DNA encompassing the APOE locus with attendant human regulatory regions, but the fact that the transgene constructs did not match precisely among the three apoE alleles, combined with uncontrolled integration loci and copy numbers, renders interpretation of results subject to ambiguity. 

Phrase: "(44"

Phrase: ")"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "large segments of human genomic DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1517520:Genomic Segment [Conceptual Entity]
   719   C0441635:Segment [Spatial Concept]

Phrase: "encompassing"

Phrase: "the APOE locus with attendant human regulatory regions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "but"

Phrase: "the fact"

Phrase: "that"

Phrase: "the transgene constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "match"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:match [Research Activity]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "precisely among the three apoE alleles,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002085:Alleles [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205449:Three [Quantitative Concept]

Phrase: "combined with uncontrolled integration loci"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205195:Combined [Qualitative Concept]
   760   C0205318:Uncontrolled [Qualitative Concept]
   760   C1158478:Integration [Genetic Function]
   760   C1705422:Integration [Machine Activity]
   726 E C0336789:Combine [Manufactured Object]
   726   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "copy numbers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1707513:Copy Number [Quantitative Concept]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1948062:Copy [Manufactured Object]

Phrase: "renders"

Phrase: "interpretation of results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0459471:Interpretation [Intellectual Product]
   790   C3173575:Interpretation [Clinical Attribute]

Phrase: "subject to ambiguity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C2346729:Ambiguity [Qualitative Concept]
   928 E C1549102:Ambiguous [Organism Attribute]
   928 E C3539086:Ambiguous [Intellectual Product]
Processing 00000000.tx.143: Sullivan et al. 

Phrase: "Sullivan et al."
Processing 00000000.tx.144: (29,30) pioneered the generation of human apoE3 and apoE2 mice, and Knouff et al. 

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: "pioneered"

Phrase: "the generation of human apoE3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "apoE2 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "Knouff et al."
Processing 00000000.tx.145: (31) recently reported their apoE4 mice. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "their apoE4 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.146: They took advantage of homologous recombination to replace a segment of DNA at the Apoe locus with homologous segments of human genomic DNA. 

Phrase: "They"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of homologous recombination to"

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "a segment of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441635:Segment [Spatial Concept]

Phrase: "at the Apoe locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "with homologous segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   777 E C0205122:Segmental [Spatial Concept]

Phrase: "of human genomic DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
Processing 00000000.tx.147: The plasma TC level of their E4 homozygotes was not significantly different from that of E3 homozygotes. 

Phrase: "The plasma TC level of their E4 homozygotes"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   818   C1272107:Plasma total cholesterol level [Laboratory Procedure]
   764   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol level
   764   C0428466:Cholesterol level [Laboratory or Test Result]
   764   C0543421:Total cholesterol [Steroid]
   762   C0858034:cholesterol plasma [Laboratory Procedure]
   762 E C1442946:Cholesterol.total [Laboratory or Test Result]
   742   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   742   C0032105:Plasma [Body Substance]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not significantly different from that of E3 homozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.148: We used a targeting vector of different design employing human apoE cDNA coding region flanked by appropriate murine genomic DNAs (Fig. 1A). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a targeting vector of different design employing human apoE cDNA coding region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0442335:Vector [Spatial Concept]
   735   C1705099:Vector [Idea or Concept]

Phrase: "flanked by appropriate murine genomic DNAs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017428:Genomic [Gene or Genome]
   753   C0026809:Murine [Mammal]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1548787:Appropriate [Qualitative Concept]
   719   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719   C0230171:Flank [Body Location or Region]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.149: Hypercholesterolemia in the apoE4 knock-in mice Our homozygous apoE4 mice displayed marked hypercholesterolemia (249%) compared with the wild-type littermates (Table 1). 

Phrase: "Hypercholesterolemia in the apoE4 knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   748   C1522133:Hypercholesterolemia [Finding]

Phrase: "Our homozygous apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "marked hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   861   C1522133:Hypercholesterolemia [Finding]

Phrase: "(249%"

Phrase: ")"

Phrase: "compared with the wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: Preliminary results with our E3 homozygotes of F3 generation indicated that their average TC value is 125 mg/dl (n = 6) compared with 93 mg/dl (n = 5) for their wild-type littermates, indicating that the hypercholesterolemia of E4 mice is an allele-specific phenotype. 

Phrase: "Preliminary results with our E3 homozygotes of F3 generation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1548161:Preliminary results [Idea or Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "their average TC value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "125 mg/dl (n = 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0439269:mg dl [Quantitative Concept]
           mg%
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: "compared with 93 mg/dl (n = 5"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0439269:mg dl [Quantitative Concept]
           mg%
   774 E C3463848:dl mg [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: "for their wild-type littermates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "indicating"

Phrase: "that"

Phrase: "the hypercholesterolemia of E4 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   760   C1522133:Hypercholesterolemia [Finding]

Phrase: "is"

Phrase: "an allele-specific phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.151: The apparent discrepancy in the cholesterol phenotype between Knouff et al.s E4 mice and ours is not likely due to a difference in the fat or cholesterol content of the mouse diet, because a high fat chow did not differentiate cholesterol phenotypes of Knouff et al.s E4 and E3 mice (31). 

Phrase: "The apparent discrepancy in the cholesterol phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1290905:Discrepancy [Finding]

Phrase: "between Knouff et al.s E4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "ours"

Phrase: "is"

Phrase: "not likely due to a difference"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0332148:Likely [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]
   753   C1518422:Not [Functional Concept]
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "in the fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "or"

Phrase: "cholesterol content of the mouse diet,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "because"

Phrase: "a high fat chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0324335:chow [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "cholesterol phenotypes of Knouff et al.s E4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0031437:Phenotypes [Organism Attribute]
   711 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "E3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.152: Nevertheless, a possibility cannot be excluded that some other component of the diet may have contributed to the discrepancy. 

Phrase: "Nevertheless,"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "that"

Phrase: "some other component of the diet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "may"

Phrase: "have"

Phrase: "contributed to the discrepancy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1290905:Discrepancy [Finding]
   737   C1880177:Contribute [Activity]
Processing 00000000.tx.153: This can be tested by exchanging mice or diets. 

Phrase: "This"

Phrase: "can"

Phrase: "be"

Phrase: "tested by exchanging mice"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0392366:tested [Intellectual Product]
   770   C0678640:exchanging [Social Behavior]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "or"

Phrase: "diets."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0012155:Diets [Food]
   966 E C1442959:Diet [Organism Function]
   966 E C1519433:DIET [Therapeutic or Preventive Procedure]
   966 E C2983588:DIET [Food]
   916 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.154: The difference in the construction of transgenes may also be responsible. 

Phrase: "The difference in the construction of transgenes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "responsible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1273518:Responsible [Finding]
Processing 00000000.tx.155: The Apoe/APOE gene of our knock-in mice lacks introns 2 and 3, whereas Knouff et al.s mice (31) carry a chimeric intron 1 and human introns 2 and 3, possibly leading to a subtle difference in the regulation of apoE expression. 

Phrase: "The Apoe/APOE gene of our knock-in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C2350597:Gene Knock-In [Molecular Biology Research Technique]
   762   C1412481:APOE gene [Gene or Genome]
   762   C1417166:MICE gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "introns 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "whereas"

Phrase: "Knouff et al.s mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "a chimeric intron 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0008109:chimeric [Organism]
   827   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   755 E C0333678:Chimerism [Organism Attribute]

Phrase: "and"

Phrase: "human introns 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086418:Human [Human]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "leading to a subtle difference"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of apoE expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.156: This could be tested by careful comparative analyses of apoE protein expression. 

Phrase: "This"

Phrase: "could"

Phrase: "be"

Phrase: "tested by careful comparative analyses of apoE protein expression."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   766   C1882495:Protein Expression Analysis [Laboratory Procedure]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1171362:protein expression [Genetic Function]
   743   C0683941:comparative analysis [Research Activity]
   741   C0523476:apolipoprotein test [Laboratory Procedure]
   741   C0788300:PROTEIN TEST [Medical Device]
   741   C1275991:test e [Diagnostic Procedure]
   741   C1514534:Protein Analysis [Molecular Biology Research Technique]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0392366:tested [Intellectual Product]
   706   C0002778:Analysis [Laboratory Procedure]
   706 E C0022885:Test [Laboratory Procedure]
   706 E C0039593:Test [Functional Concept]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]
Processing 00000000.tx.157: Our analysis of lipoprotein profile (Fig. 4) showed a large increase in VLDL- and LDL-cholesterol without significant changes in the HDL-cholesterol. 

Phrase: "Our analysis of lipoprotein profile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a large increase in VLDL-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "LDL-cholesterol without significant changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0023824:Cholesterol, LDL [Biologically Active Substance,Steroid]
   806   C0202117:LDL Cholesterol [Laboratory Procedure]
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "in the HDL-cholesterol."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0023822:High Density Lipoprotein Cholesterol [Biologically Active Substance,Lipid]
   923   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   902   C1522133:high cholesterol [Finding]
   861   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]
   741 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.158: Interestingly in the humans also, 4 carriers have increased plasma cholesterol and LDL (45,46). 

Phrase: "Interestingly in the humans also,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Humans [Human]

Phrase: "4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "have"

Phrase: "increased plasma cholesterol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C3276464:Increased cholesterol [Finding]
   901   C0858034:plasma cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "LDL (45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.159: ApoE4 has been shown to distribute relatively preferentially to VLDL rather than HDL when compared with apoE3 (47,48). 

Phrase: "ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distribute [Functional Concept]

Phrase: "relatively preferentially to VLDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0523560:VLDL [Laboratory Procedure]

Phrase: "rather than"

Phrase: "HDL"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "when"

Phrase: "compared with apoE3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   790   C1707455:Compared [Activity]

Phrase: "(47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.160: A higher catabolic rate of apoE4-bearing VLDL (49) has been offered as an explanation of higher plasma cholesterol levels observed among human 4 carriers (45). 

Phrase: "A higher catabolic rate of apoE4-bearing VLDL (49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "offered as an explanation of higher plasma cholesterol levels"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0201950:cholesterol levels [Laboratory Procedure]
   764   C0428466:cholesterol levels [Laboratory or Test Result]
   764   C0858034:plasma cholesterol [Laboratory Procedure]
   751   C1522133:high cholesterol level [Finding]
           high cholesterol
   742   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   742   C0032105:Plasma [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C0681841:Explanation [Intellectual Product]
   742   C1444648:Offered [Finding]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   708   C0205250:High [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708   C1299351:High [Qualitative Concept]
   708 E C1547707:Level [Geographic Area]
   708   C2700149:HIGH [Intellectual Product]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed among human 4 carriers"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007294:carriers [Finding]
   760   C0086418:Human [Human]
   760   C1441672:Observed [Functional Concept]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.161: In this explanation apoE4-bearing VLDL delivers cholesterol more efficiently to the liver, and also accelerates the conversion of VLDL remnants to LDL driving its accumulation. 

Phrase: "In this explanation apoE4-bearing VLDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0523560:VLDL [Laboratory Procedure]

Phrase: "delivers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "cholesterol more efficiently to the liver,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]

Phrase: "and"

Phrase: "also"

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the conversion of VLDL remnants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "to LDL driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004379:Driving [Daily or Recreational Activity]
   827 E C0013126:Drive [Mental Process]

Phrase: "its accumulation."
Processing 00000000.tx.162: Both will lead to a down-regulation of LDL receptor and further accumulation of LDL. 

Phrase: "Both"

Phrase: "will"

Phrase: "lead to a down-regulation of LDL receptor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C0949469:Receptor Down-Regulation [Molecular Function]
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0034821:LDL Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1149327:LDL receptor [Molecular Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "further accumulation of LDL."
Processing 00000000.tx.163: It is tempting to speculate that a similar mechanism may operate in our 4/4 mice. 

Phrase: "It"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "a similar mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "operate in our 4/4 mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C3242339:operate [Functional Concept]
Processing 00000000.tx.164: Brain cholesterol As a first step toward understanding the physiological and pathological roles of apoE, brain lipids were measured in our apoE4 mice. 

Phrase: "Brain cholesterol As a first step"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "toward understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological roles of apoE,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "brain lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "measured in our apoE4 mice."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   760   C0444706:Measured [Qualitative Concept]
   760   C2984964:APOE4 [Laboratory Procedure]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.165: In contrast to the serum, the homozygote brain showed 32% reduction in total cholesterol, and 17% reduction in phospholipids, when compared with the wild-type littermates. 

Phrase: "In contrast to the serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "the homozygote brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "32% reduction in total cholesterol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "17% reduction in phospholipids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "compared with the wild-type littermates."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.166: These measurements mostly reflect cell-associated lipids rather than lipoproteins in the interstitial fluid, and thus do not necessarily contradict the elevated cholesterol level found in the serum. 

Phrase: "These measurements mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "cell-associated lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0023779:Lipids [Lipid]
   734   C0699040:cell associated [Cell Component]

Phrase: "rather than"

Phrase: "lipoproteins in the interstitial fluid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "thus"

Phrase: "do"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "contradict"

Phrase: "the elevated cholesterol level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0020443:Elevated Cholesterol [Disease or Syndrome]
   901   C0201950:cholesterol level [Laboratory Procedure]
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "found in the serum."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.167: Nonetheless, it raises a possibility that the mechanisms of brain parenchymal cholesterol metabolism and traffic may be substantially different from those on the other side of the bloodbrain barrier. 

Phrase: "Nonetheless,"

Phrase: "it"

Phrase: "raises"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the mechanisms of brain parenchymal cholesterol metabolism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "traffic"

Phrase: "may"

Phrase: "be"

Phrase: "substantially different from those on the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "other side of the bloodbrain barrier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441987:Side [Spatial Concept]
Processing 00000000.tx.168: In fact, apoE and apoAI are the major apolipoproteins, but apoB is not found, in the CNS (5), and LRP is considered to be an important apoE receptor in the brain in addition to the LDL receptor (13). 

Phrase: "In fact,"

Phrase: "apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "apoAI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085201:Apo A-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412468:APOA1 [Gene or Genome]
  1000   C2698168:APOA1 [Laboratory Procedure]

Phrase: "are"

Phrase: "the major apolipoproteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003591:Apolipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "apoB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003593:Apo-B [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "in the CNS"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "LRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an important apoE receptor in the brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0051300:Receptor, Apolipoprotein E [Amino Acid, Peptide, or Protein,Receptor]
   800   C1416912:APOLIPOPROTEIN E RECEPTOR [Gene or Genome]
           APOLIPOPROTEIN RECEPTOR
   800   C2987172:Apolipoprotein E Receptor [Amino Acid, Peptide, or Protein]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in addition to the LDL receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034821:LDL Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1149327:LDL receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.169: The decreased brain cholesterol content of the E4 knock-in mice is not likely to be the consequence of interspecies inconsistency between the human apoE and the murine apoE receptors in the brain, since our preliminary results indicate that the brain cholesterol content of our apoE3 knock-in mice is not significantly different from that of wild-type littermates. 

Phrase: "The decreased brain cholesterol content of the E4 knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0423896:Content [Mental Process]
   738   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "not likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "the consequence of interspecies inconsistency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "between the human apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the murine apoE receptors in the brain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0051300:Receptor, Apolipoprotein E [Amino Acid, Peptide, or Protein,Receptor]
   783   C1416912:APOLIPOPROTEIN E RECEPTOR [Gene or Genome]
           APOLIPOPROTEIN RECEPTOR
   783   C2987172:Apolipoprotein E Receptor [Amino Acid, Peptide, or Protein]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "since"

Phrase: "our preliminary results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the brain cholesterol content of our apoE3 knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "not significantly different from that of wild-type littermates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.170: An interesting possibility would be some property peculiar to the apoE4 protein, such as a hypothetical ability to extract cholesterol from myelin more efficiently, that manifests itself primarily in the CNS tissues. 

Phrase: "An interesting possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "some property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871161:Property [Qualitative Concept]
  1000   C1882134:Property [Conceptual Entity]
  1000   C2347695:Property [Entity]

Phrase: "peculiar to the apoE4 protein,"

Phrase: "such as a hypothetical ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "cholesterol from myelin more efficiently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "that"

Phrase: "manifests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "itself primarily in the CNS tissues."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0927232:Central Nervous System [Body System]
   800   C1269563:Central nervous system [Body System]
   782   C1281813:Central nervous tissue [Body Part, Organ, or Organ Component]
   770   C0027763:Nervous System [Body System]
   770   C0422837:NERVOUS SYSTEM [Finding]
   770   C1269560:Nervous system [Body System]
   767   C0027757:nervous tissues [Tissue]
   750 E C1762608:Nervous tissue [Tissue]
   744   C0027769:Nervous [Sign or Symptom]
   744   C0040300:Tissues [Tissue]
   744   C0205099:Central [Spatial Concept]
   744   C0449913:System [Functional Concept]
   744   C0599851:Nervous [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1879652:Central - [Laboratory Procedure]
   715 E C0205494:Neurologic [Qualitative Concept]
   711 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.171: Published studies of human apoE knock-in mice by Sullivan et al. and Knouff et al. 

Phrase: "Published studies of human apoE knock-in mice"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C0178693:human studies [Research Activity]
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "by Sullivan et al."

Phrase: "and"

Phrase: "Knouff et al."
Processing 00000000.tx.172: (2931) were devoted to hematologic and vascular studies, and to our knowledge no data are available for comparison regarding their brain cholesterol levels. 

Phrase: "(2931"

Phrase: ")"

Phrase: "were"

Phrase: "devoted to hematologic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018943:Hematologic [Biomedical Occupation or Discipline]
   790   C0205488:Haematologic [Functional Concept]
   718 E C0200627:HEMATOLOGY [Laboratory Procedure]

Phrase: "and"

Phrase: "vascular studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and to our knowledge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376554:Knowledge [Intellectual Product]
   770   C1515981:And [Idea or Concept]

Phrase: "no data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "available for comparison regarding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "their brain cholesterol levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.173: The reduced cholesterol content in the brains of apoE4 knock-in mice is particularly intriguing because of recent recognition that A can be detected in association with cholesterol-rich membrane microdomains (50,51), and thatcholesterol availability affects APP processing in cultured cells (5257) and in the brain (58). 

Phrase: "The reduced cholesterol content in the brains of apoE4 knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0423896:Content [Mental Process]
   736   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "particularly"

Phrase: "intriguing because of recent recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332185:Recent [Temporal Concept]
   760   C0524637:Recognition [Mental Process]

Phrase: "that"

Phrase: "A"

Phrase: "can"

Phrase: "be"

Phrase: "detected in association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0442726:Detected [Finding]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with cholesterol-rich membrane microdomains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887868:Membrane Microdomains [Cell Component]

Phrase: "(50,"

Phrase: "51"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "thatcholesterol availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Availability [Functional Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP processing in cultured cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0033666:protein processing [Molecular Function]
   757   C0230625:cell processing [Cell Component]
   748   C1709694:Processing [Activity]

Phrase: "(5257"

Phrase: ")"

Phrase: "and in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.174: Contents of cholesterol and other lipids have been found to be decreased in AD brains (27). 

Phrase: "Contents of cholesterol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0456205:Contents [Conceptual Entity]
   790   C1552853:contents [Idea or Concept]
   756 E C0423896:Content [Mental Process]

Phrase: "and"

Phrase: "other lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "decreased in AD brains"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   781   C0006111:Brain Disease [Disease or Syndrome]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.175: Whether this is the result of degenerative loss of synapses and cells, or it has etiological significance remains to be studied. 

Phrase: "Whether"

Phrase: "this"

Phrase: "is"

Phrase: "the result of degenerative loss of synapses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "and"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "it"

Phrase: "has"

Phrase: "etiological significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.176: Much more needs to be learned about cholesterol metabolism in aging and AD brains. 

Phrase: "Much more"

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "learned about cholesterol metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1156530:cholesterol metabolism [Molecular Function]
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0023185:learned [Mental Process]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "in aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "AD brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimers disease [Disease or Syndrome]
Processing 00000000.tx.177: A more detailed analysis of cholesterol and other lipids in the brains of our apoE4 mice is also urgent, as well as analyses of APP metabolism there. 

Phrase: "A more detailed analysis of cholesterol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "other lipids in the brains of our apoE4 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0023779:Lipids [Lipid]

Phrase: "is"

Phrase: "also urgent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439609:Urgent [Temporal Concept]
   861   C3272275:URGENT [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "analyses of APP metabolism there."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1514534:Protein Analysis [Molecular Biology Research Technique]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]
Processing 00000000.tx.178: Equally awaited is the study of doubly transgenic mice to be produced by breeding the apoE humanized lines of mice with the APP-overexpressing transgenic lines that develop pathological changes (59,60) and to determine how human apoE isoforms differentially affect A production and deposition in the brain. 

Phrase: "Equally"

Phrase: "awaited"

Phrase: "is"

Phrase: "the study of doubly transgenic mice to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "be"

Phrase: "produced by breeding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006159:Breeding [Organism Function]

Phrase: "the apoE humanized lines of mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0205132:lines [Spatial Concept]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "with the APP-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "develop"

Phrase: "pathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "(59,"

Phrase: "60"

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "how human apoE isoforms differentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0443526:Apolipoprotein E isoform [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   799   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "deposition in the brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.179: Dynamic up-regulation of apoE expression after physical injury has long been known in the peripheral nervous system and CNS (19,21,22). 

Phrase: "Dynamic up-regulation of apoE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "after physical injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "has"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "been"

Phrase: "known in the peripheral nervous system"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0206417:Peripheral Nervous System [Body System]
   814 E C0869552:nervous peripheral system [Therapeutic or Preventive Procedure]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205100:Peripheral [Spatial Concept]
   753   C0205309:Known [Qualitative Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   734 E C0205494:Neurologic [Qualitative Concept]
   732   C0031119:Peripheral Nerves [Body Part, Organ, or Organ Component]
   732   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "CNS"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(19,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.180: More recent studies on experimental ischemia (61), head injury in humans (62) and brain lesions in apoE-deficient mice (63) further support the idea that apoE plays a part in neural repair processes. 

Phrase: "More recent studies on experimental ischemia"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0681814:experimental studies [Research Activity]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "(61"

Phrase: ")"

Phrase: ","

Phrase: "head injury in humans"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0018674:Head injury [Injury or Poisoning]
   770   C0018670:Head [Body Location or Region]
   770   C1281590:Head [Body Part, Organ, or Organ Component]
   770   C1706305:Head [Manufactured Object]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]
   715 E C0205096:Cephalic [Spatial Concept]

Phrase: "(62"

Phrase: ")"

Phrase: "and"

Phrase: "brain lesions in apoE-deficient mice"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0221505:brain lesions [Disease or Syndrome]
   757   C1521713:Mouse Brain [Tissue]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0221198:lesions [Finding]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   714 E C1546698:Lesion [Intellectual Product]

Phrase: "(63"

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a part in neural repair processes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1268169:Nerve part [Body Part, Organ, or Organ Component]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.181: Perhaps this is a reflection of increased importance of cholesterol recycling in the brain parenchyma, which does not have ready access to the cholesterol in general circulation (64). 

Phrase: "Perhaps"

Phrase: "this"

Phrase: "is"

Phrase: "a reflection of increased importance of cholesterol recycling"

Phrase: "in the brain parenchyma,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "ready"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1318963:Readiness [Finding]

Phrase: "access to the cholesterol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0444454:Access [Spatial Concept]
   770   C1554204:access [Idea or Concept]

Phrase: "in general circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.182: Since AD entails sporadic neuronal deaths during characteristically protracted course of the disease, small differences among apoE isoforms in the efficiency of cholesterol transport could have substantial cumulative effects on the timing of clinical onset of AD. 

Phrase: "Since"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "entails"

Phrase: "sporadic neuronal deaths during characteristically protracted course of the disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0011065:deaths [Organism Function]
   739   C1306577:DEATHS [Finding]
   707   C2754100:neuron death [Cell Function]

Phrase: "small differences among apoE isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in the efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013682:Efficiency [Quantitative Concept]
   928 E C0442799:Efficient [Qualitative Concept]

Phrase: "of cholesterol transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159709:cholesterol transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "could"

Phrase: "have"

Phrase: "substantial cumulative effects on the timing of clinical onset of AD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   736   C1280500:effects [Qualitative Concept]
   736   C1511559:Cumulative [Qualitative Concept]
   703 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.183: Such a possibility could be tested by comparing apoE3 and apoE4 mice with respect to their reactions to one-time and synchronous neuronal insults such as caused by neurotoxin administration (65) or appropriate surgical lesion experiments (66). 

Phrase: "Such"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "tested by comparing apoE3"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
   737   C1707455:Compare [Activity]

Phrase: "and"

Phrase: "apoE4 mice with respect to their reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "to one-time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C3241998:one time [Intellectual Product]
   861   C0040223:Time [Temporal Concept]
   861   C0205447:One [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "synchronous neuronal insults such as"

Phrase: "caused by neurotoxin administration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001554:Administration [Occupational Activity]
   770   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "appropriate surgical lesion experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.184: Our mice may be useful also in testing the involvement of apoE in neuronal plasticity (24,67). 

Phrase: "Our mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "be"

Phrase: "useful also in testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2984753:USE TESTING [Functional Concept]
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]

Phrase: "the involvement of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in neuronal plasticity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0027880:Neuronal Plasticity [Organ or Tissue Function]
   861   C0521390:Neuronal [Immunologic Factor]
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0027882:Neuron [Cell]
   789 E C0032167:Plastic [Substance]

Phrase: "(24,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.185: It is hoped that the apoE4 mice reported here will be useful in producing relevant animal models not only for atherosclerosis research but also for clarifying the precise role of apoE in the etiology of AD, and developing effective measures to halt the progression of the disease.  

Phrase: "It"

Phrase: "is"

Phrase: "hoped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392347:Hope [Mental Process]

Phrase: "that"

Phrase: "the apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "will"

Phrase: "be"

Phrase: "useful in producing relevant animal models"

Phrase: "not only for atherosclerosis research"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004153:Atherosclerosis [Disease or Syndrome]
   760   C0035168:research [Research Activity]
   760   C0205171:Only [Quantitative Concept]
   760   C0242481:Research [Research Activity]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also for clarifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2986669:Clarify [Activity]

Phrase: "the precise role of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "developing effective measures to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0079809:Measures [Quantitative Concept]
   812   C1879489:Measures [Functional Concept]
   779 E C0242485:Measure [Functional Concept]

Phrase: "halt"

Phrase: "the progression of the disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0242656:Disease Progression [Pathologic Function]
           progression
   797   C1947900:Disease progression NOS [Finding]
   760   C0449258:Progression [Functional Concept]
Processing 00000000.tx.186: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Mice Mice of C57BL/6N strain were obtained from Japan Clea (Tokyo, Japan). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mice Mice of C57BL/6N strain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   773   C0025914:mouse, mice [Mammal]

Phrase: "were"

Phrase: "obtained from Japan Clea"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022341:Japan [Geographic Area]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.187: ApoE-deficient mice of C57BL/6J-Apoe tm1Unc (37) were obtained from the Jackson Laboratory (Bar Harbor, ME). 

Phrase: "ApoE-deficient mice of C57BL/6J-Apoe tm1Unc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0025921:Mice, C57BL [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "(37"

Phrase: ")"

Phrase: "were"

Phrase: "obtained from the Jackson Laboratory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1301820:Obtained [Functional Concept]
   760   C3244292:laboratory [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME"

Phrase: ")."
Processing 00000000.tx.188: All mice were reared on a normal diet of MF (Oriental Yeast, Chiba, Japan) containing 4.9% fat, 0.075% cholesterol, 23.8% protein, 6.2% ash and 2.7% fiber. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "reared on a normal diet of MF (Oriental Yeast,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0184625:Normal diet [Daily or Recreational Activity]
   764   C1550560:normal diet [Therapeutic or Preventive Procedure]
   742   C0012155:Diet [Food]
   742   C0036025:yeast [Fungus]
   742   C0043392:Yeast [Food]
   742   C0043393:Yeast [Fungus]
   742   C0078988:Oriental [Population Group]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0699027:oriental [Plant]
   742   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   742   C1442959:Diet [Organism Function]
   742   C1519433:DIET [Therapeutic or Preventive Procedure]
   742   C2347086:% Normal [Quantitative Concept]
   742   C2983588:DIET [Food]

Phrase: "Chiba,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4.9% fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424612:FAT [Organism Attribute]

Phrase: "0.075% cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "23.8% protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "6.2% ash"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0994524:Ash [Plant]
   827   C0994955:ASH [Pharmacologic Substance]

Phrase: "and"

Phrase: "2.7% fiber."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0012173:Fiber [Food]
   827   C0225326:Fiber [Pharmacologic Substance]
   827   C0304068:Fiber [Plant]
   827   C1260603:Fiber [Plant]
   827   C1304649:Fiber [Tissue]
Processing 00000000.tx.189: Construction of targeting vector The targeting construct was made by two-step ligations of DNA fragments. 

Phrase: "Construction of targeting vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "The targeting construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "made by two-step ligations of DNA fragments."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   750   C1155649:DNA Ligation [Genetic Function]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0023690:Ligations [Therapeutic or Preventive Procedure]
   744   C0205448:Two [Quantitative Concept]
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C1261552:Step [Conceptual Entity]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C2825408:Step [Manufactured Object]
   711 E C1708096:Fragment [Qualitative Concept]
   711   C1881534:Make [Functional Concept]
Processing 00000000.tx.190: First, a 6.0 kb fragment including mouse Apoe gene 5' flanking region, exon 1, intron 1 and the first 18 bp of exon 2 (strain 129/SvJ), a human apoE4 cDNA fragment corresponding to nucleotides 59 to +1027 (68), and a loxP-PGK-neo-loxP (69) fragment were ligated and subcloned into pBluescript II SK (pTG1). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a 6.0 kb fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mouse Apoe gene 5' flanking region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   839   C0052202:apo E-5 [Amino Acid, Peptide, or Protein]
   799   C0017446:Region [Geographic Area]
   799   C0205147:Region [Spatial Concept]
   799   C0230171:flanking [Body Location or Region]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]

Phrase: "exon 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the first 18 bp of exon 2"

Phrase: "(strain 129/SvJ"

Phrase: ")"

Phrase: ","

Phrase: "a human apoE4 cDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to nucleotides 59 to +1027"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a loxP-PGK-neo-loxP"

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "ligated"

Phrase: "and"

Phrase: "subcloned into pBluescript II SK (pTG1"

Phrase: ")."
Processing 00000000.tx.191: The human apoE4 cDNA originated from pKCRHAPE (Japan patent 60-126989, 1985), a vector for expression of human apoE3. 

Phrase: "The human apoE4 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "originated from pKCRHAPE"

Phrase: "(Japan patent 60-126989,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022341:Japan [Geographic Area]
   812   C0030650:patent [Intellectual Product]
   812   C0175566:Patent [Spatial Concept]

Phrase: "1985"

Phrase: ")"

Phrase: ","

Phrase: "a vector for expression of human apoE3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.192: A 280bp Eco47IIISacII fragment was excised from pKCRHAPE and subcloned into pBluescript. 

Phrase: "A 280bp Eco47IIISacII fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "excised from pKCRHAPE"

Phrase: "and"

Phrase: "subcloned into pBluescript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C1883178:Subclone [Cell]
Processing 00000000.tx.193: A point mutation resulting in Cys112Arg substitution was introduced by a Pfu DNA polymerase-based mutagenesis using a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) with a pair of mutagenic primers (E34F, 5'-ACATGGAGGACGTGCGCGGCCGCCTGGTG-3'; 

Phrase: "A point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "resulting in Cys112Arg substitution"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1555721:Substitution [Idea or Concept]
   770   C1706204:Substitution [Activity]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "was"

Phrase: "introduced by a Pfu DNA polymerase-based mutagenesis"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   800   C0136227:Pfu DNA polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Pfu polymerase
   770   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0079866:Mutagenesis [Molecular Function]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1882406:PFU [Quantitative Concept]
   744   C3146302:Mutagenesis [Laboratory Procedure]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711   C1292748:introduce [Functional Concept]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a QuikChange site-directed mutagenesis kit (Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA) with a pair of mutagenic primers"

Phrase: "(E34F,"

Phrase: "5'-ACATGGAGGACGTGCGCGGCCGCCTGGTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.194: E34R, 5'-CACCAGGCGGCCGCGCACGTCCTCCATG-3'). 

Phrase: "E34R,"

Phrase: "5'-CACCAGGCGGCCGCGCACGTCCTCCATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.195: The desired point mutation and the entire coding sequences were confirmed by DNA sequence analysis. 

Phrase: "The desired point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutation [Genetic Function]
   827   C1552961:Point [Quantitative Concept]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   827   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "the entire coding sequences"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   867   C0079941:Coding Sequence [Gene or Genome]
   827   C0009219:Coding [Occupational Activity]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C0805701:Code [Intellectual Product]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "confirmed by DNA sequence analysis."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   862   C0162802:Sequence Analysis, DNA [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   806   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   797   C0200898:DNA analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1519249:Sequence [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.196: Next, a 9.0 kb fragment excised from pTG1 and a 2.6 kb fragment of mouse Apoe gene 3' flanking region were inserted into an F3 vector, which includes a thymidine kinase gene driven by the promoter of pMC1neo (70), giving rise to the targeting vector, pTG2. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "a 9.0 kb fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "excised from pTG1"

Phrase: "and"

Phrase: "a 2.6 kb fragment of mouse Apoe gene 3' flanking region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0332255:fragment [Functional Concept]
   736   C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "inserted into an F3 vector,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441587:Inserted [Health Care Activity]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a thymidine kinase gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1336633:Thymidine Kinase Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "driven by the promoter of pMC1neo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719   C0013126:Drive [Mental Process]

Phrase: "(70"

Phrase: ")"

Phrase: ","

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to the targeting vector,"

Phrase: "pTG2."
Processing 00000000.tx.197: Generation of homozygous human apoE4 knock-in mice The targeting vector, pTG2, was linearlized with SalI and electroporated into ES cells, E14TG2aIV (32), at 1000 V with a capacitance of 3 F using a Bio-Rad (Hercules, CA) Gene Pulsar. 

Phrase: "Generation of homozygous human apoE4 knock-in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "The targeting vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "pTG2,"

Phrase: "was"

Phrase: "linearlized with SalI"

Phrase: "and"

Phrase: "electroporated into ES cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0596508:Embryonic Stem Cells [Cell]
   806   C0038250:Stem cells [Cell]
   781   C1947950:Embryonic Cell [Embryonic Structure]
   760   C0007634:Cells [Cell]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "E14TG2aIV"

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "at 1000 V"

Phrase: "with a capacitance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242264:capacitance [Quantitative Concept]

Phrase: "of 3 F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bio-Rad (Hercules,"

Phrase: "CA) Gene Pulsar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0917885:Pulsar [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.198: After double selection with G418 (175 g/ml) and gancyclovir (2 M), 125 resistant clones were picked, among which seven targeted ES cell clones were identified by Southern blot analysis. 

Phrase: "After double selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "with G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(175 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "gancyclovir"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017066:Gancyclovir [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "125 resistant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "picked"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1707391:Picked [Activity]
   966 E C1826583:PICK [Gene or Genome]

Phrase: ","

Phrase: "among which seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "ES cell clones"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0009013:cell clones [Cell]
           Clones
   779 E C1522642:Clone [Tissue]
   756   C0596508:Embryonic stem cell [Cell]
   729 E C1704387:Clonal [Qualitative Concept]
   708   C1947950:Embryonic Cell [Embryonic Structure]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "identified by Southern blot analysis."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   862   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1710133:Southern [Spatial Concept]
Processing 00000000.tx.199: The targeted ES cells were injected into C57BL/6N blastocysts, which were then implanted into the pseudopregnant recipients to produce chimeric mice. 

Phrase: "The targeted ES cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   923   C0596508:Embryonic Stem Cells [Cell]
   886   C0221284:Target cells [Cell]
   886   C3272919:Target Cells [Laboratory Procedure]
   861   C0038250:Stem cells [Cell]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   812   C0007634:Cells [Cell]
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "injected into C57BL/6N blastocysts,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C1511382:C57BL/6N [Mammal]
   760   C0025921:C57BL [Mammal]
   760   C1281743:Blastocysts [Embryonic Structure]
   726 E C0005705:Blastocyst [Embryonic Structure]
   726 E C1281786:Blastocyst [Embryonic Structure]
   726   C1720154:Inject [Functional Concept]

Phrase: "which"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "implanted into the pseudopregnant recipients to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0021102:Implanted [Medical Device]
   719 E C0021107:implant [Therapeutic or Preventive Procedure]
   719 E C0332837:Implant [Injury or Poisoning]
   719   C1709854:Recipient [Human]
   719 E C1711357:Implant [Functional Concept]

Phrase: "produce"

Phrase: "chimeric mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.200: Chimeric male mice were mated to C57BL/6N females to examime germ-line transmission of the transgene. 

Phrase: "Chimeric male mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "mated to C57BL/6N females"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C1511382:C57BL/6N [Mammal]
   760   C0015780:Females [Finding]
   760   C0025921:C57BL [Mammal]
   760   C0086287:Females [Population Group]
   760   C1254211:mated [Pharmacologic Substance]
   760   C1260875:Mated [Organism Function]
   726 E C0043210:female [Population Group]
   726 E C0682323:mate [Family Group]
   726 E C1705497:Female [Qualitative Concept]
   726 E C1705498:Female [Qualitative Concept]

Phrase: "to examime germ-line transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040722:transmission [Idea or Concept]
   812   C0242781:Transmission [Pathologic Function]
   812   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "of the transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.201: The agouti coat color male offspring, which were heterozygous for the human apoE4, were mated to C57BL/6N females to produce the F2generation. 

Phrase: "The agouti"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265498:Agouti [Mammal]

Phrase: "coat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0453946:Coat [Manufactured Object]
  1000   C1522408:Coat [Qualitative Concept]
  1000   C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "color male offspring,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Offspring [Family Group]

Phrase: "which"

Phrase: "were"

Phrase: "heterozygous for the human apoE4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019425:Heterozygous [Organism Attribute]

Phrase: "were"

Phrase: "mated to C57BL/6N females to"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C1511382:C57BL/6N [Mammal]
   753   C0015780:Females [Finding]
   753   C0025921:C57BL [Mammal]
   753   C0086287:Females [Population Group]
   753   C1254211:mated [Pharmacologic Substance]
   753   C1260875:Mated [Organism Function]
   719 E C0043210:female [Population Group]
   719 E C0682323:mate [Family Group]
   719 E C1705497:Female [Qualitative Concept]
   719 E C1705498:Female [Qualitative Concept]

Phrase: "produce"

Phrase: "the F2generation."
Processing 00000000.tx.202: Mice heterozygous for the human apoE4 in theF2 generation were intercrossed to generate homozygous human apoE4 knock-in mice. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "heterozygous for the human apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019425:Heterozygous [Organism Attribute]

Phrase: "in theF2 generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "were"

Phrase: "intercrossed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "homozygous human apoE4 knock-in mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.203: Wild-type littermates from these crosses were used as controls. 

Phrase: "Wild-type littermates from these crosses"

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.204: The floxed neo in the transgene has not been eliminated from the knock-in mice described in this work. 

Phrase: "The floxed neo in the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1366752:NEO [Gene or Genome]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "eliminated from the knock-in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1517676:Knock-in [Research Activity]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0849355:Eliminated [Qualitative Concept]

Phrase: "described in this work."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.205: Genomic Southern blot analysis ES cell DNA was isolated by digesting cells in lysis buffer A (0.2% SDS, 100 g/ml of proteinase K, 200 mM NaCl, 100mM Tris pH7.5, 5 mM EDTA) at 55C overnight and dissolved with TE buffer after ethanol precipitation. 

Phrase: "Genomic Southern blot analysis ES cell DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   892   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   850   C0200898:analysis dna [Laboratory Procedure]
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated by digesting cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C0868946:digesting [Physiologic Function]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in lysis buffer A (0.2% SDS,"

Phrase: "100 g/ml of proteinase K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "200 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "100mM Tris pH7.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "5 mM EDTA) at 55C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "dissolved with TE buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1705540:TE [Conceptual Entity]
   737   C1549535:Dissolve [Functional Concept]

Phrase: "after ethanol precipitation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]
Processing 00000000.tx.206: Tail-tip DNA was isolated by digesting tail-tip clippings in lysis buffer B (1% SDS, 2 mg/ml proteinase K, 100 mM NaCl, 50 mM Tris pH 8.0, 100 mM EDTA) at 55C overnight, and dissolved with TE after phenol extraction, chloroform extraction and ethanol precipitation. 

Phrase: "Tail-tip DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1980004:tail tip [Cell Component]

Phrase: "was"

Phrase: "isolated by digesting tail-tip clippings"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C1980004:tail tip [Cell Component]
   753   C0039259:Tail [Body Part, Organ, or Organ Component]
   753   C0205409:Isolated [Functional Concept]
   753   C0868946:digesting [Physiologic Function]
   753   C1546575:Clippings [Intellectual Product]
   753   C1548221:Isolated [Idea or Concept]
   753   C1710425:Tip [Medical Device]
   753   C3282898:Tip [Qualitative Concept]
   719 E C0185010:Clipping [Therapeutic or Preventive Procedure]
   719 E C0370215:Isolate [Substance]
   719 E C1283066:Clipping [Therapeutic or Preventive Procedure]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in lysis buffer B (1% SDS,"

Phrase: "2 mg/ml proteinase K,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1708601:K' [Quantitative Concept]
   804   C1947941:Proteinase [Enzyme]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "50 mM Tris pH 8.0,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: "100 mM EDTA) at 55C overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "dissolved with TE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1705540:TE [Conceptual Entity]
   756   C1549535:Dissolve [Functional Concept]

Phrase: "after phenol extraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "chloroform extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "ethanol precipitation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]
Processing 00000000.tx.207: Genomic DNAs were digested with HindIII, analyzed by electrophoresis, and transferred to the nylon membrane. 

Phrase: "Genomic DNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "digested with HindIII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "analyzed by electrophoresis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "transferred to the nylon membrane."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.208: Transferred DNA was hybridized in hybridization buffer (7% SDS, 50% formamide, 5x SSC, 2% blocking reagent, 50 mM sodium phosphate pH 7.0, 0.1% N-lauroylsarcosine) overnight at 42C to a DIG-labelled 1.1 kb probe, corresponding to the XmnINcoI fragment in the 3' flanking region shown in Figure 1. 

Phrase: "Transferred DNA"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0348011:transferred [Functional Concept]
   827 E C0040671:Transfer [Mental Process]
   827 E C1705822:Transfer [Activity]

Phrase: "was"

Phrase: "hybridized in hybridization buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0020202:Hybridisation [Genetic Function]
   770   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(7% SDS,"

Phrase: "50% formamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016568:formamide [Organic Chemical]

Phrase: "5x SSC,"

Phrase: "2% blocking reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "50 mM sodium phosphate pH 7.0,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1% N-lauroylsarcosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0074071:Lauroyl Sarcosine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "overnight at 42C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439583:Overnight [Temporal Concept]
   790   C1419782:42C [Gene or Genome]
   790   C3538774:42C [Gene or Genome]

Phrase: "to a DIG-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321878:DIG [Neoplastic Process]

Phrase: "labelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181496:Label [Manufactured Object]
   966   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "1.1 kb probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the XmnINcoI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "in the 3' flanking region"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0949648:3' Flanking Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883633:3' Region [Nucleotide Sequence]
           3' Flank
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0230171:flanking [Body Location or Region]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "shown in Figure 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.209: The hybridized membrane was washed twice for 15 min at 68C with 0.1x SSC, 0.1% SDS, and subsequently incubated with Fab fragments of anti-DIG antibody conjugated with alkaline phosphatase. 

Phrase: "The hybridized membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice for 15 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "at 68C"

Phrase: "with 0.1x SSC,"

Phrase: "0.1% SDS,"

Phrase: "and"

Phrase: "subsequently"

Phrase: "incubated with Fab fragments of anti-DIG antibody"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0021031:Fab Fragments [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1566673:Antibody Fragments [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C1321878:DIG [Neoplastic Process]
   744   C1439852:Incubated [Laboratory Procedure]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "conjugated with alkaline phosphatase."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0522529:Conjugated [Spatial Concept]
   770   C1149880:phosphatase [Molecular Function]
   770   C1979842:Alkaline [Qualitative Concept]
   737 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.210: The chemiluminescence signal was detected using CSPD (Roche Molecular Biochemicals, Mannheim, Germany). 

Phrase: "The chemiluminescence signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CSPD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0379078:CSPD [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Roche Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.211: To clone the human apoE4 cDNA from the knock-in mice, poly(A)+ RNA was isolated from the liver, and first-strand cDNA was synthesized using SuperScript Preamplification System (Gibco BRL, Rockville, MD). 

Phrase: "To clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "the human apoE4 cDNA from the knock-in mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "+ RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from the liver,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   770   C2346688:LIVER [Food]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "first-strand cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SuperScript Preamplification System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Gibco BRL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "Rockville,"

Phrase: "MD)."
Processing 00000000.tx.212: The human apoE4 cDNA was amplified by PCR using oligonucleotides MF (CAATTGGGAAGATGAAGGTTCTGTGGGCTG) and TR (CGGCGTTCAGTGATTGTCGCTGGGCACAGG). 

Phrase: "The human apoE4 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotides MF (CAATTGGGAAGATGAAGGTTCTGTGGGCTG"

Phrase: ")"

Phrase: "and"

Phrase: "TR (CGGCGTTCAGTGATTGTCGCTGGGCACAGG"

Phrase: ")."
Processing 00000000.tx.213: The PCR fragment of the expected size was cloned into pGEM-T-Easy Vector (Promega, Madison, WI), and sequenced to confirm the absence of inadvertent mutations in the expressed transgene. 

Phrase: "The PCR fragment of the expected size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned into pGEM-T-Easy Vector"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0009013:cloned [Cell]
   753   C0049896:PGE-M [Eicosanoid]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332219:Easy [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the absence of inadvertent mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the expressed transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.214: Western blot analysis Human serum (0.5 l) or mouse fasted sera (1 l) were combined with 10 l of SDSPAGE sample buffer (2.3% SDS, 5% 2-mercaptoethanol, 10% glycerol, 62.5 mM TrisHCl buffer, pH 6.8) and boiled for 3 min. 

Phrase: "Western blot analysis Human serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0086418:Human [Human]
   804   C0229671:Serum [Body Substance]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   717   C0949466:Western blot analysis [Laboratory Procedure]

Phrase: "(0.5 l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "or"

Phrase: "mouse fasted sera"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0229671:Sera [Body Substance]
   827   C1151254:SerA [Molecular Function]
   793 E C1546774:Serum [Intellectual Product]
   793 E C1550100:Serum [Body Substance]

Phrase: "(1 l)"

Phrase: "were"

Phrase: "combined with 10 l of SDSPAGE sample buffer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0205195:Combined [Qualitative Concept]
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]
   711 E C0336789:Combine [Manufactured Object]

Phrase: "(2.3% SDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1519042:2-3 [Research Activity]

Phrase: "5% 2-mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "62.5 mM TrisHCl buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "boiled for 3 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.215: Whole brains were homogenized in 2 ml of homogenization buffer (5 mM EDTA, 1 mM PMSF, 10 M leupeptin, 10 M pepstatin A, 150 mM NaCl, 10 mM sodium phosphate pH 7.2) in a glassTeflon Potter homogenizer. 

Phrase: "Whole brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "homogenized in 2 ml of homogenization buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "(5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM PMSF,"

Phrase: "10 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10 M pepstatin A,"

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10 mM sodium phosphate pH 7.2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "in a glassTeflon Potter homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.216: Aliquots of the homogenate containing 50g protein were dissolved with 10 l of SDSPAGE sample buffer and boiled for 3 min. 

Phrase: "Aliquots of the homogenate containing 50g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "dissolved with 10 l of SDSPAGE sample buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]
   711   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "boiled for 3 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.217: The samples were separated by 10% acrylamide SDSPAGE, and transferred to PVDF membrane. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated by 10% acrylamide SDSPAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "transferred to PVDF membrane."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0071710:PVDF [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]
Processing 00000000.tx.218: The blots were blocked with 3% non-fat dried milk/phosphate-buffered saline, and incubated for 1 h at room temperature with the primary antibodies: rat monoclonal 868E5 (35), hamster monoclonal 874B7 (35) or mouse monoclonal Ab 412-1-7 (36) followed by washing and appropriate biotinylated secondary antibodies. 

Phrase: "The blots"

Phrase: "were"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "with 3% non-fat dried milk/phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   793   C0031701:phosphate [Organophosphorus Compound]
   793   C0036082:Saline [Substance]
   793   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "rat monoclonal 868E5"

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "hamster monoclonal 874B7"

Phrase: "(35"

Phrase: ")"

Phrase: "or"

Phrase: "mouse monoclonal Ab 412-1-7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]
   799   C0746619:monoclonal [Finding]

Phrase: "(36"

Phrase: ")"

Phrase: "followed by washing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0441648:Washing [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "appropriate biotinylated secondary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.219: The signal was detected by using Vectastain ABC kit (Vector, Burlingame, CA) combined with either chloronaphthol as chromogen or enhanced chemiluminescence (Pierce, Rockford, IL). 

Phrase: "The signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Vectastain ABC kit (Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "combined with either chloronaphthol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0205195:Combined [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "as chromogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052799:Chromogen [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.220: Lipid and lipoprotein analysis Three or four mice of each sex of each genotype (10 weeks) were fasted for 6 h, and blood was collected from abdominal vena cava under Nembutal anesthesia. 

Phrase: "Lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "lipoprotein analysis Three"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205449:Three [Quantitative Concept]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "or"

Phrase: "four mice of each sex of each genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "(10 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "fasted for 6 h,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "collected from abdominal vena cava"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0042460:Vena cava [Body Part, Organ, or Organ Component]
   806   C1280190:Vena cava [Body Part, Organ, or Organ Component]
   760   C0000726:Abdominal [Body Location or Region]
   760   C0447122:Vena [Body Part, Organ, or Organ Component]
   760   C0521083:Kava [Plant]
   760   C0939882:KAVA [Organic Chemical,Pharmacologic Substance]
   760   C1413046:CAVA [Gene or Genome]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1547290:Kava [Intellectual Product]

Phrase: "under Nembutal anesthesia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   861   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   745 E C0002932:Anaesthetic [Pharmacologic Substance]
Processing 00000000.tx.221: Brains were removed immediately after exsanguination, and frozen on dry ice. 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "exsanguination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232100:Exsanguination [Pathologic Function]

Phrase: "and"

Phrase: "frozen on dry ice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013239:Dry Ice [Inorganic Chemical]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0205222:Dry [Qualitative Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1512080:Dry [Qualitative Concept]
Processing 00000000.tx.222: Chloroformmethanol (1:1) extracts of the brains were dried under nitrogen gas and re-extracted with choloformmethanol (2:1). 

Phrase: "Chloroformmethanol"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "extracts of the brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C2828366:Extract [Substance]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "dried under nitrogen gas"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0301294:Nitrogen gas [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0017110:Gas [Chemical Viewed Structurally]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0596601:Gas [Sign or Symptom]
   770   C1512080:Dried [Qualitative Concept]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C2827485:Dried [Body Substance]
   737 E C0011682:Dry [Natural Phenomenon or Process]
   737 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "re-extracted with choloformmethanol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C2986904:RE [Idea or Concept]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.223: The lower phase was evaporated and extracted with isopropanol for analyses. 

Phrase: "The lower phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "evaporated"

Phrase: "and"

Phrase: "extracted with isopropanol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0022237:Isopropanol [Organic Chemical,Pharmacologic Substance]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "for analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]
Processing 00000000.tx.224: Levels of total serum cholesterol and triglyceride were determined using enzymatic assay kits, Determiner TC555 and Determiner TGS555 (Kyowa Medex, Tokyo, Japan), respectively. 

Phrase: "Levels of total serum cholesterol"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   865   C1445957:Serum total cholesterol level [Laboratory Procedure]
   835   C0587184:cholesterol levels serum [Laboratory Procedure]
   835   C1287371:cholesterol levels serum [Laboratory or Test Result]
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "triglyceride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041004:Triglyceride [Biologically Active Substance,Lipid]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "enzymatic assay kits,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C1690540:Kits [Qualitative Concept]
   793 E C0812225:KIT [Medical Device]
   793 E C1150635:KIT [Molecular Function]
   793 E C1705212:Kit [Medical Device]
   793 E C1705213:KIT [Medical Device]
   793 E C3273202:Kit [Manufactured Object]
   734   C2717977:Enzymatic Assay [Laboratory Procedure]

Phrase: "Determiner TC555"

Phrase: "and"

Phrase: "Determiner TGS555"

Phrase: "(Kyowa Medex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025053:medex [Professional or Occupational Group]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.225: For FPLC size fractionation, 50 l of mouse serum was injected onto Superose 6 column (FPLC system; Amersham Pharmacia Biotech, Uppsala, Sweden) and eluted at a constant flow rate of 0.5 ml/min with 1 mM EDTA and 50 mM phosphate buffer. 

Phrase: "For FPLC size fractionation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0016640:fractionation [Laboratory Procedure]
   799   C0524811:fractionation [Therapeutic or Preventive Procedure]
   799   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   734   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]

Phrase: "50 l of mouse serum"

Phrase: "was"

Phrase: "injected onto Superose 6 column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]
   726   C1720154:Inject [Functional Concept]

Phrase: "(FPLC system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   771   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "; Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "eluted at a constant flow rate of 0.5 ml/min"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0439445:mL/min [Quantitative Concept]
   756   C0444499:0/5 [Quantitative Concept]
   756   C2826285:Flow Rate [Quantitative Concept]
   754   C2986811:Rate Constant [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C0702093:/min [Temporal Concept]
   738   C0806140:Flow [Natural Phenomenon or Process]
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]
   738   C1547014:*Constant [Quantitative Concept]
   738   C1948059:Constant [Qualitative Concept]

Phrase: "with 1 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "50 mM phosphate buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.226: Fractions of 0.5 ml were collected and cholesterol concentrations measured enzymatically, and apoE distribution was studied by western blotting. 

Phrase: "Fractions of 0.5 ml"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1264633:Fraction of [Quantitative Concept]
           Fractions
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "cholesterol concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "enzymatically,"

Phrase: "and"

Phrase: "apoE distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "studied by western blotting."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]
Processing 00000000.tx.227: Immunohistochemistry Mice were fixed under deep Nembutal anesthesia by cardiac perfusion with chilled 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.2. 

Phrase: "Immunohistochemistry Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fixed under deep Nembutal anesthesia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0475747:Deep anaesthesia [Finding]
   760   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   760   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   760   C0205125:Deep [Spatial Concept]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C0702208:Nembutal [Organic Chemical,Pharmacologic Substance]
   760   C2827483:Fixed [Body Substance]

Phrase: "by cardiac perfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "with chilled 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in 0.1 M phosphate buffer pH 7.2."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   850   C0950275:M 7 [Organic Chemical,Pharmacologic Substance]
   812   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C1882074:pH 7 [Qualitative Concept]
   793   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   793   C0031701:phosphate [Organophosphorus Compound]
   793   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0441923:M+ [Intellectual Product]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.228: Brains were removed, post-fixed overnight in the same fixative at 4C, and cryoprotected in 20% sucrose/phosphate-buffered saline. 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "post-fixed"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0231441:Fixed [Finding]
   861   C0443218:Fixed [Qualitative Concept]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   861   C2827483:Fixed [Body Substance]
   789 E C1514253:Postal [Functional Concept]

Phrase: "overnight in the same fixative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439583:Overnight [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "cryoprotected in 20% sucrose/phosphate-buffered saline."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.229: Cryostat sections of 13 m were cut and picked up on glass. 

Phrase: "Cryostat sections of 13 m"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "picked up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1707391:Picked [Activity]
   799 E C1826583:PICK [Gene or Genome]

Phrase: "on glass."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]
Processing 00000000.tx.230: The sections were exposed overnight either to hamster mAb 884F11 (35) as hybridoma supernatant or rabbit anti-human ApoE(IBL#18171) at 1:200 dilution in Tris-buffered saline with 0.3% Triton X-100. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "overnight either to hamster mAb 884F11"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0018557:Hamster [Mammal]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0439583:Overnight [Temporal Concept]
   748   C0746619:monoclonal [Finding]

Phrase: "(35"

Phrase: ")"

Phrase: "as"

Phrase: "hybridoma supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "or"

Phrase: "rabbit anti-human ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0523511:APOE [Laboratory Procedure]
   812   C1412481:APOE [Gene or Genome]

Phrase: "(IBL#18171"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "200 dilution in Tris-buffered saline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "with 0.3% Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]
Processing 00000000.tx.231: The bound antibodies were visualized either by biotinylated anti-hamster Ig (#127-065-160, 1:200; 

Phrase: "The bound antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "either"

Phrase: "by biotinylated anti-hamster Ig (#127-065-160,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0018557:Hamster [Mammal]
   795   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C3541296:IG [Idea or Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.232: Jackson ImmunoResearch, West Grove, PA) or biotinylated anti-rabbit Ig (RPN1004, 1:200; 

Phrase: "Jackson ImmunoResearch,"

Phrase: "West Grove,"

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "or"

Phrase: "biotinylated anti-rabbit Ig (RPN1004,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.233: Amersham Pharmacia Biotech), followed by Oregon Green-labeled streptavidin (S-6369, 1:200; 

Phrase: "Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "followed by Oregon Green-labeled streptavidin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0029195:Oregon [Geographic Area]
   753   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   753   C0332583:Green [Qualitative Concept]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C1719822:Follow [Intellectual Product]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "("

Phrase: "S-"

Phrase: "6369,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.234: Molecular Probes, Eugene, OR). 

Phrase: "Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.235: Fluorescence images were examined under Olympus BX50 fluorescence microscope, captured by Hamamatsu C5810 Color Chilled 3CCD Camera and MacSCOPE software, and printed by Fujix Pictrography 3000.  

Phrase: "Fluorescence images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "examined under Olympus BX50 fluorescence microscope,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0181839:Microscope [Medical Device]
   753   C0332128:Examined [Finding]
   753   C1706379:Microscope [Medical Device]

Phrase: "captured by Hamamatsu C5810 Color Chilled 3CCD Camera"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0009393:Color [Natural Phenomenon or Process]
   744   C0179533:Camera [Medical Device]
   744   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   744   C1654607:Camera [Eukaryote]
   744   C1705245:Color [Pharmacologic Substance]
   744   C1706254:CAMERA [Medical Device]
   711   C0085593:Chill [Sign or Symptom]

Phrase: "and"

Phrase: "MacSCOPE software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "printed by Fujix Pictrography 3000."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0033161:print [Occupational Activity]
Processing 00000000.tx.236: ACKNOWLEDGEMENTS  This work was possible through the use of the E14TG2aIV ES cells generously made available by Dr A.G. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "possible through the use of the E14TG2aIV ES cells generously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0332149:Possible [Qualitative Concept]
   738   C1705910:Possible [Qualitative Concept]
   738   C2362652:Possible [Qualitative Concept]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "available by Dr A.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]
Processing 00000000.tx.237: Smith. 

Phrase: "Smith."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]
Processing 00000000.tx.238: Dr T. 

Phrase: "Dr T."
Processing 00000000.tx.239: Kitamoto kindly provided us with the neo cassette. 

Phrase: "Kitamoto kindly"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "us with the neo cassette."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0450240:Cassette [Medical Device]
   760   C1366752:NEO [Gene or Genome]
   760   C1706210:Cassette [Manufactured Object]
Processing 00000000.tx.240: We acknowledge a helpful gift of cDNA for human apoE3 from Dr M. 

Phrase: "We"

Phrase: "acknowledge"

Phrase: "a helpful gift of cDNA"

Phrase: "for human apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "from Dr M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.241: Seki and his colleagues at the Mitsubishi Chemical Corporation Yokohama Research Center. 

Phrase: "Seki"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272348:Seki [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "his colleagues at the Mitsubishi Chemical Corporation Yokohama Research Center."
Processing 00000000.tx.242: Our thanks are due to Dr N. 

Phrase: "Our"

Phrase: "thanks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "are due to Dr N."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0031831:DR [Professional or Occupational Group]
   760   C1551058:Are [Quantitative Concept]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   760   C3540849:DR [Idea or Concept]
Processing 00000000.tx.243: Nukina for his generous gift of Ab 412-1-12-2 specific to human apoE4, to Dr K. 

Phrase: "Nukina for his generous gift"

Phrase: "of Ab 412-1-12-2 specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0205369:Specific [Qualitative Concept]
   799   C1552740:specific [Intellectual Product]

Phrase: "to human apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "to Dr K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.244: Ikeda for a gift of anti-apoE antiserum, and to Mr S. 

Phrase: "Ikeda for a gift of anti-apoE antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3613423:Ikeda [Eukaryote]

Phrase: "and to Mr S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   770   C2347167:Mr. [Conceptual Entity]
Processing 00000000.tx.245: Kamijo for expert support concerning mouse stocks. 

Phrase: "Kamijo for expert support concerning mouse stocks."
Processing 00000000.tx.246: We are grateful to Drs S. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Drs S."
Processing 00000000.tx.247: Yokoyama, H.

Phrase: "Yokoyama,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.248: Yamaguchi and K. 

Phrase: "Yamaguchi"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.249: Yanagisawa for helpful discussions, and to Dr K. 

Phrase: "Yanagisawa for helpful discussions,"

Phrase: "and to Dr K."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031831:DR [Professional or Occupational Group]
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1515981:And [Idea or Concept]
   770   C1707664:DR [Biomedical or Dental Material]
   770   C1708601:K' [Quantitative Concept]
   770   C2348314:Dr. [Conceptual Entity]
   770   C3540849:DR [Idea or Concept]
Processing 00000000.tx.250: Imahori for encouragement.  

Phrase: "Imahori for encouragement."
Processing 00000000.tx.251: FOOTNOTES  + Present address: Laboratory for Neurodegeneration and Signaling, Brain Science Institute, RIKEN (Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan  To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  + Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Laboratory for Neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022877:Laboratory [Manufactured Object,Organization]
   790   C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "Signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "Brain Science Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "RIKEN"

Phrase: "(Institute of Physical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Chemical Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "2-1 Hirosawa,"

Phrase: "Wako,"

Phrase: "Saitama 351-0198,"

Phrase: "Japan  To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022341:Japan [Geographic Area]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.252: Tel: +81 42 724 6276; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+81 42 724 6276"

Phrase: ";"
Processing 00000000.tx.253: Fax: +81 42 724 6314; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+81 42 724 6314"

Phrase: ";"
Processing 00000000.tx.254: Email: fujita@ls.m-kagaku.co.jp  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Mahley, R.W. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "fujita@ls."

Phrase: "m-"

Phrase: "kagaku.co.jp"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Mahley,"

Phrase: "R.W."
Processing 00000000.tx.255: (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "cholesterol transport protein with expanding role in cell biology."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159709:cholesterol transport [Cell Function]
   762 E C0599895:protein transport [Cell Function]
   762 E C1159772:Protein Transport [Cell Function]
   742   C0005528:Transport, NOS [Cell Function]
           Biologic Transport
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1317949:Transport [Manufactured Object]
   742   C3495449:transport [Medical Device]
Processing 00000000.tx.256: Science 240, 622630.[ISI][Medline] 2 Elshourbagy, N.A., Liao, W.S., Mahley, R.W. and Taylor, J.M. 

Phrase: "Science 240,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "622630."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 2 Elshourbagy,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Liao,"

Phrase: "W.S.,"

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Apolipoprotein E mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "abundant in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "adrenals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "as well as in the liver,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "is"

Phrase: "present in other peripheral tissues of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "marmosets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006764:Marmosets [Mammal]
Processing 00000000.tx.258: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.259: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.260: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.261: USA, 82, 203207.[Abstract] 3 Boyles, J.K., Pitas, R.E., Wilson, E., Mahley, R.W. and Taylor, J.M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "82,"

Phrase: "203207."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3 Boyles,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Pitas,"

Phrase: "R.E.,"

Phrase: "Wilson,"

Phrase: "E.,"

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with astrocytic glia of the central nervous system"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   790   C0927232:Central Nervous System [Body System]
   790   C1269563:Central nervous system [Body System]
   764   C0027763:Nervous System [Body System]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0422837:NERVOUS SYSTEM [Finding]
   764   C1269560:Nervous system [Body System]
   742   C0027769:Nervous [Sign or Symptom]
   742   C0027836:Glia [Cell]
   742   C0205099:Central [Spatial Concept]
   742   C0449913:System [Functional Concept]
   742   C0521395:Astrocytic [Body Location or Region]
   742   C0599851:Nervous [Functional Concept]
   742   C1087003:Glia [Plant]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   742   C1879652:Central - [Laboratory Procedure]
   709 E C0205494:Neurologic [Qualitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and with nonmyelinating glia of the peripheral nervous system."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   790   C0206417:Peripheral Nervous System [Body System]
   781 E C0869552:nervous peripheral system [Therapeutic or Preventive Procedure]
   764   C0027763:Nervous System [Body System]
   764   C0422837:NERVOUS SYSTEM [Finding]
   764   C1269560:Nervous system [Body System]
   742   C0027769:Nervous [Sign or Symptom]
   742   C0027836:Glia [Cell]
   742   C0205100:Peripheral [Spatial Concept]
   742   C0449913:System [Functional Concept]
   742   C0599851:Nervous [Functional Concept]
   742   C1087003:Glia [Plant]
   742   C1515981:And [Idea or Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   709 E C0205494:Neurologic [Qualitative Concept]
   707   C0031119:Peripheral Nerves [Body Part, Organ, or Organ Component]
   707   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.263: J.Clin. 

Phrase: "J."

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.264: Invest., 76, 15011513.[ISI][Medline] 4 Pitas, R.E., Boyles, J.K., Lee, S.H., Foss, D. and Mahley, R.W. 

Phrase: "Invest.,"

Phrase: "76,"

Phrase: "15011513."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 4 Pitas,"

Phrase: "R.E.,"

Phrase: "Boyles,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Foss,"

Phrase: "D."

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R.W."
Processing 00000000.tx.265: (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein Econtaining lipoproteins. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "synthesize"

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "metabolize"

Phrase: "apolipoprotein Econtaining lipoproteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.266: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.267: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.268: Acta, 917, 148161.[ISI][Medline] 5 Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D. and Weisgraber, K.H. 

Phrase: "Acta,"

Phrase: "917,"

Phrase: "148161."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Pitas,"

Phrase: "R.E.,"

Phrase: "Boyles,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hui,"

Phrase: "D."

Phrase: "and"

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.269: (1987) Lipoproteins and their receptors in the central nervous system. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their receptors in the central nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   713   C0034837:Receptors, Neural [Cell Component]
Processing 00000000.tx.270: Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. 

Phrase: "Characterization of the lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "in cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "identification of apolipoprotein B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "E (LDL) receptors in the brain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0034821:Receptors, LDL [Amino Acid, Peptide, or Protein,Receptor]
   756 E C1149327:LDL receptor [Molecular Function]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.271: J. 

Phrase: "J."
Processing 00000000.tx.272: Biol. 

Phrase: "Biol."
Processing 00000000.tx.273: Chem., 262, 1435214360.[Abstract/Free FullText] 6 Chiba, H., Mitamura, T., Fujisawa, S., Ogata, A., Aimoto, Y., Tashiro, K. and Kobayashi, K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "262,"

Phrase: "1435214360."

Phrase: "[Abstract/Free FullText"

Phrase: "] 6 Chiba,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mitamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujisawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331815:Fujisawa [Health Care Related Organization]

Phrase: "S."

Phrase: ","

Phrase: "Ogata,"

Phrase: "A.,"

Phrase: "Aimoto,"

Phrase: "Y.,"

Phrase: "Tashiro,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kobayashi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.274: (1991) Apolipoproteins in rat cerebrospinal fluid: a comparison with plasma lipoprotein metabolism and effect of aging. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Apolipoproteins in rat cerebrospinal fluid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003591:Apolipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a comparison with plasma lipoprotein metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "effect of aging."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.275: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.276: Lett., 133, 207210.[ISI][Medline] 7 LaDu, M.J., Gilligan, S.M., Lukens, J.R., Cabana, V.G., Reardon, C.A., Van Eldik, L.J. and Holtzman, D.M. 

Phrase: "Lett.,"

Phrase: "133,"

Phrase: "207210."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7 LaDu,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Gilligan,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Lukens,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Cabana,"

Phrase: "V.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Reardon,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Van Eldik,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.277: (1998) Nascent astrocyte particles differ from lipoproteins in CSF. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nascent astrocyte particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "differ from lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in CSF."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
Processing 00000000.tx.278: J. 

Phrase: "J."
Processing 00000000.tx.279: Neurochem., 70, 20702081.[ISI][Medline] 8 Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. 

Phrase: "Neurochem.,"

Phrase: "70,"

Phrase: "20702081."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Strittmatter,"

Phrase: "W.J.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.280: (1993) Apolipoprotein E: high-avidity binding to -amyloid and increased frequency of type 4 allele in late-onset familial Alzheimers disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "high-avidity binding to -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "increased frequency of type 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in late-onset familial Alzheimers disease."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimers disease [Disease or Syndrome]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.281: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.282: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.283: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.284: USA, 90, 19771981.[Abstract] 9 Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. and Gauthier, S. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "19771981."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 9 Poirier,"

Phrase: "J.,"

Phrase: "Davignon,"

Phrase: "J.,"

Phrase: "Bouthillier,"

Phrase: "D."

Phrase: ","

Phrase: "Kogan,"

Phrase: "S."

Phrase: ","

Phrase: "Bertrand,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gauthier,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.285: (1993) Apolipoprotein E polymorphism and Alzheimers disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.286: Lancet, 342, 697699.[ISI][Medline] 10 Roses, A.D. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "342,"

Phrase: "697699."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 10 Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035853:Roses [Plant]
   827 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.287: (1996) Apolipoprotein E alleles as risk factors in Alzheimers disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E alleles as risk factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.288: Annu. 

Phrase: "Annu."
Processing 00000000.tx.289: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.290: Med., 47, 387400.[ISI][Medline] 11 Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K. 

Phrase: "Med.,"

Phrase: "47,"

Phrase: "387400."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 Namba,"

Phrase: "Y.,"

Phrase: "Tomonaga,"

Phrase: "M."

Phrase: ","

Phrase: "Kawasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Otomo,"

Phrase: "E."

Phrase: "and"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.291: (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimers disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Apolipoprotein E immunoreactivity in cerebral amyloid deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "neurofibrillary tangles in Alzheimers disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "kuru plaque amyloid in Creutzfeldt-Jakob disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0002726:amyloid disease [Disease or Syndrome]
   774   C0333463:amyloid plaque [Acquired Abnormality]
   774   C2936349:Plaque, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.292: Brain Res., 541, 163166.[ISI][Medline] 12 Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X. and Hirai, S. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "541,"

Phrase: "163166."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sugihara,"

Phrase: "S."

Phrase: ","

Phrase: "Nakazato,"

Phrase: "Y.,"

Phrase: "Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X."

Phrase: "and"

Phrase: "Hirai,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.293: (1994) Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer -amyloid deposition. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Presence of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on extracellular neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and on meningeal blood vessels"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   806   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   773 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   773 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   760   C0521400:Meningeal [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   735 E C1558950:VASCULAR [Finding]
   735 E C1801960:Vascular [Qualitative Concept]
   714 E C0005767:Blood [Tissue]
   714 E C0005768:blood [Body Substance]
   714 E C0229664:Blood [Body Substance]
   714 E C0392895:Bloods [Population Group]

Phrase: "precedes"

Phrase: "the Alzheimer -amyloid deposition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011560:Amyloid deposition [Pathologic Function]
   901   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.294: Acta Neuropathol. 

Phrase: "Acta Neuropathol."
Processing 00000000.tx.295: (Berl.), 88, 413419.[ISI][Medline] 13 Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T. 

Phrase: "(Berl."

Phrase: ")"

Phrase: ","

Phrase: "88,"

Phrase: "413419."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 13 Rebeck,"

Phrase: "G.W., Reiter,"

Phrase: "J.S.,"

Phrase: "Strickland,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.296: (1993) Apolipoprotein E in sporadic Alzheimers disease: allelic variation and receptor interactions. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E in sporadic Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "allelic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "receptor interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1372999:Receptor Interactions [Molecular Function]
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.297: Neuron, 11, 575580.[ISI][Medline] 14 Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D. and Roses, A.D. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "11,"

Phrase: "575580."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 14 Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Crain,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Hulette,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Joo,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.298: (1993) Increased amyloid -peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Increased amyloid -peptide deposition in cerebral cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0011560:Amyloid deposition [Pathologic Function]
   774   C1705760:Amyloid Deposition [Finding]
   748   C0333562:Deposition [Functional Concept]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.299: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.300: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.301: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.302: USA, 90, 96499653.[Abstract] 15 Wisniewski, T., Golabek, A., Matsubara, E., Ghiso, J. and Frangione, B. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "96499653."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15 Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Golabek,"

Phrase: "A.,"

Phrase: "Matsubara,"

Phrase: "E.,"

Phrase: "Ghiso,"

Phrase: "J."

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.303: (1993) Apolipoprotein E: binding to soluble Alzheimers -amyloid. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "binding to soluble Alzheimers -amyloid."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0243122:binding [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.304: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.305: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.306: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.307: Commun., 192, 359365.[ISI][Medline] 16 LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S. and Frail, D.E. 

Phrase: "Commun.,"

Phrase: "192,"

Phrase: "359365."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 16 LaDu,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Falduto,"

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Manelli,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reardon,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Getz,"

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Frail,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871754:Frail [Finding]
   928 E C0424594:Frailty [Finding]

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.308: (1994) Isoform-specific binding of apolipoprotein E to -amyloid. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Isoform-specific binding of apolipoprotein E to -amyloid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C2247768:apolipoprotein binding [Molecular Function]
   744   C0205369:Specific [Qualitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1552740:specific [Intellectual Product]
Processing 00000000.tx.309: J. 

Phrase: "J."
Processing 00000000.tx.310: Biol. 

Phrase: "Biol."
Processing 00000000.tx.311: Chem., 269, 2340323406.[Abstract/Free FullText] 17 Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.-M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "2340323406."

Phrase: "[Abstract/Free FullText"

Phrase: "] 17 Strittmatter,"

Phrase: "W.J.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Huang,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.312: (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Isoform-specific interactions of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "with microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "implications for Alzheimer disease."
Processing 00000000.tx.313: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.314: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.315: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.316: USA, 91, 1118311186.[Abstract/Free FullText] 18 Mller, H.W., Gebicke-Hrter, P.J., Hangen, D.H. and Shooter, E.M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "91,"

Phrase: "1118311186."

Phrase: "[Abstract/Free FullText"

Phrase: "] 18 Mller,"

Phrase: "H.W., Gebicke-Hrter,"

Phrase: "P.J.,"

Phrase: "Hangen,"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Shooter,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.317: (1985) A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. 

Phrase: "(1985"

Phrase: ")"

Phrase: "A specific 37,000-dalton protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "accumulates in regenerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0334213:regenerating [Functional Concept]

Phrase: "but"

Phrase: "not in nonregenerating mammalian nerves."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0024660:Mammalian [Mammal]
   760   C0027740:Nerves [Tissue]
   760   C1518422:Not [Functional Concept]
   726 E C0027757:NERVE [Tissue]
   726 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.318: Science, 228, 499501.[ISI][Medline] 19 Ignatius, M.J., Gebicke-Hrter, P.J., Skene, J.H.P., Schilling, J.W., Weisgraber, K.H., Mahley, R.W. and Shooter, E.M. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "228,"

Phrase: "499501."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 19 Ignatius,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1670412:Ignatius [Plant]

Phrase: "M."

Phrase: "J.,"

Phrase: "Gebicke-Hrter,"

Phrase: "P.J.,"

Phrase: "Skene,"

Phrase: "J.H.P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Schilling,"

Phrase: "J.W., Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Shooter,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.319: (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Expression of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during nerve degeneration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0027746:Nerve Degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C1880269:Degeneration [Functional Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "regeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034963:Regeneration [Organ or Tissue Function]
Processing 00000000.tx.320: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.321: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.322: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.323: USA, 83, 11251129.[Abstract] 20 Snipes, G.J., McGuire, C.B., Norden, J.J. and Freeman, J.A. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "83,"

Phrase: "11251129."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20 Snipes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325808:Snipe [Bird]

Phrase: "G.J.,"

Phrase: "McGuire,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Norden,"

Phrase: "J.J."

Phrase: "and"

Phrase: "Freeman,"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.324: (1986) Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Nerve injury"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0161479:Nerve injury [Injury or Poisoning]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "stimulates"

Phrase: "the secretion of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "by nonneuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0027836:Non-neuronal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.325: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.326: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.327: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.328: USA, 83, 11301134.[Abstract] 21 Boyles, J.K., Zoellner, C.D., Anderson, L.J., Kosik, L.M., Pitas, R.E., Weisgraber, K.H., Hui, D.Y., Mahley, R.W., Gebicke-Hrter, P.J., Ignatius, M.J. and Shooter, E.M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "83,"

Phrase: "11301134."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 21 Boyles,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Zoellner,"

Phrase: "C.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012358:c d [Therapeutic or Preventive Procedure]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Kosik,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Pitas,"

Phrase: "R.E.,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hui,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Mahley,"

Phrase: "R.W., Gebicke-Hrter,"

Phrase: "P.J.,"

Phrase: "Ignatius,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1670412:Ignatius [Plant]

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Shooter,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. 

Phrase: "(1989"

Phrase: ")"

Phrase: "A role for apolipoprotein E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "apolipoprotein A-I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085201:Apolipoprotein A-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0003592:Apolipoprotein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "low density lipoprotein receptors in cholesterol transport"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   853   C0034821:Receptors, Low Density Lipoprotein [Amino Acid, Peptide, or Protein,Receptor]
   840   C0023824:Low Density Lipoprotein Cholesterol [Biologically Active Substance,Steroid]
   820 E C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   814   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   778   C0065059:Receptors, Lipoprotein [Amino Acid, Peptide, or Protein,Receptor]
   774   C0065055:cholesterol lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   774   C0860920:Low cholesterol [Finding]
   774   C1326470:lipoprotein transport [Cell Function]
   757   C0599283:receptor density [Genetic Function]
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0178587:density [Quantitative Concept]
   748   C0205251:low [Qualitative Concept]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]

Phrase: "during regeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "and"

Phrase: "remyelination of the rat sciatic nerve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0334220:Remyelination [Organ or Tissue Function]
Processing 00000000.tx.330: J. 

Phrase: "J."
Processing 00000000.tx.331: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.332: Invest., 83, 10151031.[ISI][Medline] 22 Poirier, J., Hess, M., May, P.C. and Finch, C.E. 

Phrase: "Invest.,"

Phrase: "83,"

Phrase: "10151031."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 22 Poirier,"

Phrase: "J.,"

Phrase: "Hess,"

Phrase: "M."

Phrase: ","

Phrase: "May,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.333: (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Astrocytic apolipoprotein E mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GFAP mRNA in hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "after entorhinal cortex lesioning."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0221198:Lesion [Finding]
   793   C1546698:Lesion [Intellectual Product]
   734   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   734   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
Processing 00000000.tx.334: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.335: Brain Res., 11, 97106.[ISI][Medline] 23 Poirier, J., Bacchichet, A., Dea, D. and Gauthier, S. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "11,"

Phrase: "97106."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 23 Poirier,"

Phrase: "J.,"

Phrase: "Bacchichet,"

Phrase: "A.,"

Phrase: "Dea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512006:DEA [Health Care Related Organization]

Phrase: "D."

Phrase: "and"

Phrase: "Gauthier,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.336: (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cholesterol synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599474:cholesterol synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "lipoprotein reuptake during synaptic remodelling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599702:reuptake [Cell Function]

Phrase: "in hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in adult rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.337: Neuroscience, 55, 8190.[ISI][Medline] 24 Poirier, J. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "8190."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 24 Poirier,"

Phrase: "J."
Processing 00000000.tx.338: (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimers disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E in animal models of CNS injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and in Alzheimers disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.339: Trends Neurosci., 17, 525530.[ISI][Medline] 25 Goodrum, J.F. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "17,"

Phrase: "525530."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 25 Goodrum,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.340: (1990) Cholesterol synthesis is down-regulated during regeneration of peripheral nerve. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Cholesterol synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599474:cholesterol synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "down-regulated during regeneration of peripheral nerve."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0031119:Peripheral nerve [Body Part, Organ, or Organ Component]
   778   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]
   774   C0027756:Nerve Regeneration [Cell Function]
   748   C0027740:Nerve [Tissue]
   748   C0027757:NERVE [Tissue]
   748   C0034963:Regeneration [Organ or Tissue Function]
   748   C0205100:Peripheral [Spatial Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.341: J. 

Phrase: "J."
Processing 00000000.tx.342: Neurochem., 54, 17091715.[ISI][Medline] 26 Svennerholm, L., Bostrm, K., Jungbjer, B. and Olsson, L. 

Phrase: "Neurochem.,"

Phrase: "54,"

Phrase: "17091715."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 26 Svennerholm,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bostrm,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jungbjer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Olsson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.343: (1994) Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Membrane lipids of adult human brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025249:Membrane Lipids [Cell Component,Lipid]
   753   C0023779:Lipids [Lipid]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]

Phrase: ":"

Phrase: "lipid composition of frontal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0486616:Composition [Clinical Attribute]
   770   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "temporal lobe in subjects of age 20"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0039485:Temporal Lobe [Body Part, Organ, or Organ Component]
   778   C1268978:Temporal lobe [Body Part, Organ, or Organ Component]
   748   C0442043:Temporal [Spatial Concept]
   748   C0796494:lobe [Body Part, Organ, or Organ Component]
   748   C1428707:Lobe [Gene or Genome]
   748   C2362314:Temporal [Temporal Concept]
   748   C3539671:Lobe [Gene or Genome]

Phrase: "to 100 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.344: J. 

Phrase: "J."
Processing 00000000.tx.345: Neurochem., 63, 18021811.[ISI][Medline] 27 Svennerholm, L. and Gottfries, C.-G. 

Phrase: "Neurochem.,"

Phrase: "63,"

Phrase: "18021811."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27 Svennerholm,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gottfries,"

Phrase: "C.-G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.346: (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). 

Phrase: "(1994"

Phrase: ")"

Phrase: "Membrane lipids,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025249:Membrane Lipids [Cell Component,Lipid]
   861   C0023779:Lipids [Lipid]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "selectively"

Phrase: "diminished in Alzheimer brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0205216:Diminished [Quantitative Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "synapse loss as a primary event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in early-onset form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]
   734   C1833334:Early-onset [Finding]

Phrase: "(type I)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "demyelination in late-onset form"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0011304:Demyelination [Pathologic Function]

Phrase: "(type II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441730:Type II [Classification]

Phrase: ")."
Processing 00000000.tx.347: J.

Phrase: "J."
Processing 00000000.tx.348: Neurochem., 62, 10391047.[ISI][Medline] 28 Michikawa, M. and Yanagisawa, K. 

Phrase: "Neurochem.,"

Phrase: "62,"

Phrase: "10391047."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 28 Michikawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.349: (1998) Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neuronal cell death under conditions of suppressed de novo cholesterol synthesis."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   775   C2754100:neuronal cell death [Cell Function]
           neuron death
   756   C0007587:Cell Death [Cell Function]
   738   C0007634:Cell [Cell]
   738   C0011065:Death [Organism Function]
   738   C1269647:Cell [Cell]
   738   C1306577:Death, NOS [Finding]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   718   C2936320:Synthetic Cell [Manufactured Object]
Processing 00000000.tx.350: J. 

Phrase: "J."
Processing 00000000.tx.351: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.352: Res., 54, 5867.[ISI][Medline] 29 Sullivan, P.M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R.L., Quarfordt, S.H. and Maeda, N. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "54,"

Phrase: "5867."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 29 Sullivan,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Mezdour,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Aratani,"

Phrase: "Y.,"

Phrase: "Knouff,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Najib,"

Phrase: "J.,"

Phrase: "Reddick,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Quarfordt,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.353: (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Targeted replacement of the mouse apolipoprotein E gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0872178:gene replacement [Therapeutic or Preventive Procedure]
   744   C0035139:Replacement [Therapeutic or Preventive Procedure]
   744   C0559956:Replacement [Functional Concept]
   744   C1555302:Replacement [Idea or Concept]

Phrase: "with the common human APOE3 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "diet-induced hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   827   C1522133:Hypercholesterolemia [Finding]

Phrase: "and"

Phrase: "atherosclerosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.354: J. 

Phrase: "J."
Processing 00000000.tx.355: Biol. 

Phrase: "Biol."
Processing 00000000.tx.356: Chem., 272, 1797217980.[Abstract/Free FullText] 30 Sullivan, P.M., Mezdour, H., Quarfordt, S.H. and Maeda, N. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "272,"

Phrase: "1797217980."

Phrase: "[Abstract/Free FullText"

Phrase: "] 30 Sullivan,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Mezdour,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Quarfordt,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.357: (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Type III hyperlipoproteinemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020479:Hyperlipoproteinemia, Type III [Disease or Syndrome]
   827   C0020476:Hyperlipoproteinaemia [Disease or Syndrome]
   734   C0441731:Type III [Classification]

Phrase: "and"

Phrase: "spontaneous atherosclerosis in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "resulting from gene replacement of mouse Apoe"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C0872178:gene replacement [Therapeutic or Preventive Procedure]
   774   C1412481:APOE gene [Gene or Genome]
           APOE
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Gene [Gene or Genome]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0035139:Replacement [Therapeutic or Preventive Procedure]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0559956:Replacement [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1555302:Replacement [Idea or Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "with human APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "*2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.358: J. 

Phrase: "J."
Processing 00000000.tx.359: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.360: Invest., 102, 130135.[Abstract/Free FullText] 31 Knouff, C., Hinsdale, M.E., Mezdour, H., Altenburg, M.K., Watanabe, M., Quarfordt, S.H., Sullivan, P.M. and Maeda, N. 

Phrase: "Invest.,"

Phrase: "102,"

Phrase: "130135."

Phrase: "[Abstract/Free FullText"

Phrase: "] 31 Knouff,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hinsdale,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Mezdour,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Altenburg,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Watanabe,"

Phrase: "M."

Phrase: ","

Phrase: "Quarfordt,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sullivan,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.361: (1999) ApoE structure determines VLDL clearance and atherosclerosis risk in mice. 

Phrase: "(1999"

Phrase: ")"

Phrase: "ApoE structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "determines"

Phrase: "VLDL clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2612555:VLDL clearance [Cell Function]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "atherosclerosis risk in mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.362: J. 

Phrase: "J."
Processing 00000000.tx.363: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.364: Invest., 103, 15791586.[Abstract/Free FullText] 32 Hooper, M., Hardy, K., Handyside, A., Hunter, S. and Monk, M. 

Phrase: "Invest.,"

Phrase: "103,"

Phrase: "15791586."

Phrase: "[Abstract/Free FullText"

Phrase: "] 32 Hooper,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Handyside,"

Phrase: "A.,"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Monk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0682252:monk [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.365: (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. 

Phrase: "(1987"

Phrase: ")"

Phrase: "HPRT-deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011155:Deficient [Functional Concept]
   861   C1636779:% deficient [Quantitative Concept]

Phrase: "(Lesch-Nyhan"

Phrase: ")"

Phrase: "mouse embryos"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0013935:Embryos [Embryonic Structure]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "derived from germline colonization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017473:Germ Line [Cell]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "by cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.366: Nature, 326, 292295.[ISI][Medline] 33 Das, H.K., McPherson, J., Bruns, G.A.P., Karathanasis, S.K. and Breslow, J.L. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "326,"

Phrase: "292295."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 33 Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   861   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "H.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "McPherson,"

Phrase: "J.,"

Phrase: "Bruns,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.P.,"

Phrase: "Karathanasis,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "J.L."
Processing 00000000.tx.367: (1985) Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Isolation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "characterization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "mapping to chromosome 19 of the human apolipoprotein E gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   775   C1517491:Gene Mapping, Human [Research Activity]
   757   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
           Gene Mapping
   739   C1283195:Mapping [Activity]
Processing 00000000.tx.368: J. 

Phrase: "J."
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: Chem., 260, 62406247.[Abstract/Free FullText] 34 Weisgraber, K.H. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "260,"

Phrase: "62406247."

Phrase: "[Abstract/Free FullText"

Phrase: "] 34 Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.371: (1994) Apolipoprotein E: structurefunction relationships. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "structurefunction relationships."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0439849:Relationships [Qualitative Concept]
   827 E C1705630:Relationship [Idea or Concept]
   827 E C1706279:Relationship [Idea or Concept]
   827 E C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.372: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.373: Prot. 

Phrase: "Prot."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0555903:PROT [Laboratory Procedure]
  1000   C1420218:PROT [Gene or Genome]
Processing 00000000.tx.374: Chem., 45, 249302.[ISI][Medline] 35 Fujita, S.C., Sakuta, K., Tsuchiya, R. and Hamanaka, H. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "45,"

Phrase: "249302."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 35 Fujita,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sakuta,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuchiya,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hamanaka,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.375: (1999) Apolipoprotein E is found in astrocytes but not microglia in the normal mouse brain. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "found in astrocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "but"

Phrase: "not microglia in the normal mouse brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0206116:Microglia [Cell]
Processing 00000000.tx.376: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.377: Res., 35, 123133.[ISI][Medline] 36 Nukina, N., Uchida, K., Sakamoto, T., Ide, K. and Kanazawa, I. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "35,"

Phrase: "123133."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 36 Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.378: (1995) Monoclonal antibody against the polymorphic site distinguishes apolipoprotein E4 from other isoforms. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Monoclonal antibody against the polymorphic site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "distinguishes"

Phrase: "apolipoprotein E4 from other isoforms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.379: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.380: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.381: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.382: Commun., 216, 467472.[ISI][Medline] 37 Piedrahita, J.A., Zhang, S.H., Hagaman, J.R., Oliver, P.M. and Maeda, N. 

Phrase: "Commun.,"

Phrase: "216,"

Phrase: "467472."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 37 Piedrahita,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Zhang,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hagaman,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Oliver,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.383: (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Generation of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a mutant apolipoprotein E gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   902   C0678941:mutant gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "inactivated by gene targeting"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0242613:Gene Targeting [Molecular Biology Research Technique]
   802 E C1332838:Target Gene [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]
   770   C1521840:Targeting [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in embryonic stem cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.384: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.385: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.386: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.387: USA, 89, 44714475.[Abstract] 38 Wetterau, J.R., Aggerbeck, L.P., Rall Jr, S.C. and Weisgraber, K.H. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "89,"

Phrase: "44714475."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 38 Wetterau,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Aggerbeck,"

Phrase: "L.P.,"

Phrase: "Rall Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "S.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.388: (1988) Human apolipoprtoein E3 in aqueous solution. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Human apolipoprtoein E3 in aqueous solution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1537525:E3 [Gene or Genome]
Processing 00000000.tx.389: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.390: Evidence for two structural domains. 

Phrase: "Evidence for two structural domains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.391: J. 

Phrase: "J."
Processing 00000000.tx.392: Biol. 

Phrase: "Biol."
Processing 00000000.tx.393: Chem., 263, 62406248.[Abstract/Free FullText] 39 Smith, J.D., Sikes, J. and Levin. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "263,"

Phrase: "62406248."

Phrase: "[Abstract/Free FullText"

Phrase: "] 39 Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Sikes,"

Phrase: "J."

Phrase: "and"

Phrase: "Levin."
Processing 00000000.tx.394: J.A. 

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.395: (1998) Human apolipoprotein E allele-specific brain expressing transgenic mice. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Human apolipoprotein E allele-specific brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "expressing"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.396: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.397: Aging, 19, 407413.[ISI][Medline] 40 Sun, Y., Wu, S., Bu, G., Onifade, M.K., Patel, S.N., LaDu, M.J., Fagan, A.M. and Holtzman, D.M. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "19,"

Phrase: "407413."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 40 Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038817:Sun [Natural Phenomenon or Process]
   861   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S."

Phrase: ","

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Onifade,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Patel,"

Phrase: "S."

Phrase: "N., LaDu,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Fagan,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: (1998) Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Glial fibrillary acidic protein-apolipoprotein E"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1325793:glial fibrillary acidic protein [Cell Component]
   734   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]

Phrase: "(apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "astrocyte-specific expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "differing biological effects of astrocyte-secreted apoE3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "apoE4 lipoproteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.399: J. 

Phrase: "J."
Processing 00000000.tx.400: Neurosci., 18, 32613272.[Abstract/Free FullText] 41 Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R.E., Mahley, R.W. and Mucke, L. 

Phrase: "Neurosci.,"

Phrase: "18,"

Phrase: "32613272."

Phrase: "[Abstract/Free FullText"

Phrase: "] 41 Raber,"

Phrase: "J.,"

Phrase: "Wong,"

Phrase: "D."

Phrase: ","

Phrase: "Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "Orth,"

Phrase: "M."

Phrase: ","

Phrase: "Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Pitas,"

Phrase: "R.E.,"

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.401: (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Isoform-specific effects of human apolipoprotein E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on brain function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0678908:brain function [Organ or Tissue Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "revealed in ApoE knockout mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0206745:Knock-out Mice [Mammal]
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0443289:Revealed [Qualitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1412481:APOE [Gene or Genome]
   760   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ":"

Phrase: "increased susceptibility of females."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.402: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.403: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.404: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.405: USA, 95, 1091410919.[Abstract/Free FullText] 42 Zhang, S.H., Reddick, R.L., Piedrahita, J.A. and Maeda, N. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "1091410919."

Phrase: "[Abstract/Free FullText"

Phrase: "] 42 Zhang,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Reddick,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Piedrahita,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.406: (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Spontaneous hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   861   C1522133:Hypercholesterolemia [Finding]

Phrase: "and"

Phrase: "arterial lesions in mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0221198:lesions [Finding]
   737 E C1546698:Lesion [Intellectual Product]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "apolipoprotein E."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.407: Science, 258, 468471.[ISI][Medline] 43 Plump, A.S., Smith, J.D., Hayek, T., Aalto-Setl, K., Walsh, A., Verstuyft, J.G., Rubin, E.M. and Breslow, J.L. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "258,"

Phrase: "468471."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 43 Plump,"

Phrase: "A.S.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Hayek,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aalto-Setl,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Walsh,"

Phrase: "A.,"

Phrase: "Verstuyft,"

Phrase: "J.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "J.L."
Processing 00000000.tx.408: (1992) Severe hypercholesterolemia and atherosclerosis in aplipoprotein E-deficient mice created by homologous recombination in ES cells. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Severe hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   861   C1522133:Hypercholesterolemia [Finding]

Phrase: "and"

Phrase: "atherosclerosis in aplipoprotein E-deficient mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "created by homologous recombination"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0599773:Homologous Recombination [Genetic Function]
   833   C1707531:Created By [Qualitative Concept]
   833   C2984295:Homologous recombination [Functional Concept]
   770   C0034865:Recombination [Genetic Function]
   770   C1334043:Homologous [Gene or Genome]
   770   C1706214:Created [Activity]
   737 E C3244320:create [Functional Concept]

Phrase: "in ES cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.409: Cell, 71, 343353.[ISI][Medline] 44 Xu, P.-T., Schmechel, D., Rothrock-Christian, T., Burkhart, D.S., Qiu, H.-L., Popko, B., Sullivan, P., Maeda, N., Saunders, A.M., Roses, A.D. and Gilbert, J.R. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "343353."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 44 Xu,"

Phrase: "P.-T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Rothrock-Christian,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008532:Christian, NOS [Idea or Concept]
   861   C0344346:Christian [Population Group]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Burkhart,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Qiu,"

Phrase: "H.-L., Popko,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Sullivan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Maeda,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.410: (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Human apolipoprotein E2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0052198:Apolipoprotein E2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C3539520:E2 [Gene or Genome]

Phrase: "E3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4 isoform-specific transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "human-like pattern of glial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "neuronal immunoreactivity in central nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in wild-type mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.411: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.412: Dis., 3, 229245.[ISI][Medline] 45 Davignon, J., Gregg, R.E. and Sing, C.F. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "229245."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 45 Davignon,"

Phrase: "J.,"

Phrase: "Gregg,"

Phrase: "R.E."

Phrase: "and"

Phrase: "Sing, C.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.413: (1988) Apolipoprotein E polymorphism and atherosclerosis. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "atherosclerosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.414: Arteriosclerosis, 8, 121.[Abstract] 46 Jarvik, G.P., Wijsman, E.M., Kukull, W.A., Schellenberg, G.D., Yu, C. and Larson, E.B. 

Phrase: "Arteriosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003850:Arteriosclerosis [Disease or Syndrome]
   928 E C0333477:Arteriosclerotic [Functional Concept]

Phrase: "8,"

Phrase: "121."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 46 Jarvik,"

Phrase: "G.P.,"

Phrase: "Wijsman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kukull,"

Phrase: "W."

Phrase: "A.,"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C."

Phrase: "and"

Phrase: "Larson,"

Phrase: "E.B."
Processing 00000000.tx.415: (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimers disease: a case-control study. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Interactions of apolipoprotein E genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "total cholesterol level,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol level
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   901   C0543421:Total cholesterol [Steroid]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex in prediction of Alzheimers disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009253:Sex [Organism Function]
   753   C0036864:Sex [Behavior]
   753   C0079399:sex [Organism Attribute]
   753   C1314687:Sex [Finding]
   753   C1522384:sex [Organism Attribute]

Phrase: ":"

Phrase: "a case-control study."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.416: Neurology, 45, 10921096.[Abstract] 47 Steinmetz, A., Jakobs, C., Motzny, S. and Kaffarnik, H. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "10921096."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 47 Steinmetz,"

Phrase: "A.,"

Phrase: "Jakobs,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Motzny,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kaffarnik,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.417: (1989) Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Differential distribution of apolipoprotein E isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in human plasma lipoproteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0544357:Human plasma [Pharmacologic Substance]
Processing 00000000.tx.418: Arteriosclerosis, 9, 405411.[Abstract] 48 Dong, L.-M., Wilson, C., Wardell, M.R., Simmons, T., Mahley, R.W., Weisgraber, K.H. and Agard, D.A. 

Phrase: "Arteriosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003850:Arteriosclerosis [Disease or Syndrome]
   928 E C0333477:Arteriosclerotic [Functional Concept]

Phrase: "9,"

Phrase: "405411."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 48 Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Wilson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wardell,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Simmons,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mahley,"

Phrase: "R.W., Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Agard,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.419: (1994) Human apolipoprotein E: role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Human apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "role of arginine 61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the lipoprotein preferences of the E3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0558295:Preferences [Idea or Concept]
   719 E C1549513:Preference [Idea or Concept]

Phrase: "and"

Phrase: "E4 isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.420: J. 

Phrase: "J."
Processing 00000000.tx.421: Biol. 

Phrase: "Biol."
Processing 00000000.tx.422: Chem., 269, 2235822365.[Abstract/Free FullText] 49 Gregg, R.E., Zech, L.A., Schaefer, E.J., Stark, D., Wilson, D. and Brewer Jr, H.B. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "2235822365."

Phrase: "[Abstract/Free FullText"

Phrase: "] 49 Gregg,"

Phrase: "R.E.,"

Phrase: "Zech,"

Phrase: "L.A.,"

Phrase: "Schaefer,"

Phrase: "E.J.,"

Phrase: "Stark,"

Phrase: "D."

Phrase: ","

Phrase: "Wilson,"

Phrase: "D."

Phrase: "and"

Phrase: "Brewer Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "H.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]
Processing 00000000.tx.423: (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Abnormal in vivo metabolism of apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.424: J. 

Phrase: "J."
Processing 00000000.tx.425: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.426: Invest., 78, 815821.[ISI][Medline] 50 Lee, S.-J., Liyanage, U., Bickel, P.E., Xia, W., Lansbury Jr, P.T. and Kosik, K.S. 

Phrase: "Invest.,"

Phrase: "78,"

Phrase: "815821."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 50 Lee,"

Phrase: "S.-"

Phrase: "J.,"

Phrase: "Liyanage,"

Phrase: "U.,"

Phrase: "Bickel,"

Phrase: "P.E.,"

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Lansbury Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K.S."
Processing 00000000.tx.427: (1998) A detergent-insoluble membrane compartment contains A in vivo. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A detergent-insoluble membrane compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185625:Compartment [Body Space or Junction]
   812   C2986730:Compartment [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "A in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.428: Nature Med., 4, 730734.[ISI][Medline] 51 Morishima-Kawashima, M. and Ihara, Y. 

Phrase: "Nature Med.,"

Phrase: "4,"

Phrase: "730734."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 51 Morishima-Kawashima,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.429: (1998) The presence of amyloid -protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The presence of amyloid -protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the detergent-insoluble membrane compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185625:Compartment [Body Space or Junction]
   812   C2986730:Compartment [Spatial Concept]

Phrase: "of human neuroblastoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.430: Biochemistry, 37, 1524715253.[ISI][Medline] 52 Bodovitz, S. and Klein, W.L. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "37,"

Phrase: "1524715253."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 52 Bodovitz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Klein,"

Phrase: "W.L."
Processing 00000000.tx.431: (1996) Cholesterol modulates -secretase cleavage of amyloid precursor protein. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "modulates -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "secretase cleavage of amyloid precursor protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
Processing 00000000.tx.432: J. 

Phrase: "J."
Processing 00000000.tx.433: Biol. 

Phrase: "Biol."
Processing 00000000.tx.434: Chem., 271, 44364440.[Abstract/Free FullText] 53 Racchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, R., Fumagalli, R., Govoni, S., Trabucchi, M. and Soma, M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "44364440."

Phrase: "[Abstract/Free FullText"

Phrase: "] 53 Racchi,"

Phrase: "M."

Phrase: ","

Phrase: "Baetta,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Salvietti,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ianna,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Franceschini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Paoletti,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fumagalli,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Govoni,"

Phrase: "S."

Phrase: ","

Phrase: "Trabucchi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Soma,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.435: (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Secretory processing of amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "inhibited by increase"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C0442805:Increase [Functional Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "in cellular cholesterol content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.436: Biochem J., 322, 893898.[ISI][Medline] 54 Ikezu, T., Trapp, B.D., Song, K.S., Schlegel, A., Lisanti, M.P. and Okamoto, T. 

Phrase: "Biochem J.,"

Phrase: "322,"

Phrase: "893898."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 54 Ikezu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Trapp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0913340:trapp [Amino Acid, Peptide, or Protein]
  1000   C1166859:trapp [Cell Component]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Schlegel,"

Phrase: "A.,"

Phrase: "Lisanti,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Okamoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.437: (1998) Caveolae, plasma membrane microdomains for -secretase-mediated processing of the amyloid precursor protein. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Caveolae,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "plasma membrane microdomains for -secretase-mediated processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0887868:Membrane Microdomains [Cell Component]

Phrase: "of the amyloid precursor protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.438: J. 

Phrase: "J."
Processing 00000000.tx.439: Biol. 

Phrase: "Biol."
Processing 00000000.tx.440: Chem., 273, 1048510495.[Abstract/Free FullText] 55 Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G. and Simons, K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "1048510495."

Phrase: "[Abstract/Free FullText"

Phrase: "] 55 Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443058:simons [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Keller,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dotti,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.441: (1998) Cholesterol depletion inhibits the generation of -amyloid in hippocampal neurons. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cholesterol depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0151718:cholesterol depletion [Pathologic Function]
   861   C0333668:Depletion [Functional Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the generation of -amyloid in hippocampal neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.442: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.443: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.444: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.445: USA, 95, 64606464.[Abstract/Free FullText] 56 Mizuno, T., Haass, C., Michikawa, M. and Yanagisawa, K (1998) Cholesterol-dependent generation of a unique amyloid -protein from apically missorted amyloid precursor protein in MDCK cells. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "64606464."

Phrase: "[Abstract/Free FullText"

Phrase: "] 56 Mizuno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Michikawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "K (1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Cholesterol-dependent generation of a unique amyloid -protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "from apically missorted amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "in MDCK cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0598829:MDCK Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.446: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.447: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.448: Acta, 1373, 119130.[ISI][Medline] 57 Mizuno, T., Nakata, M., Naiki, H., Michikawa, M., Wang, R., Haass, C. and Yanagisawa, K. 

Phrase: "Acta,"

Phrase: "1373,"

Phrase: "119130."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 57 Mizuno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakata,"

Phrase: "M."

Phrase: ","

Phrase: "Naiki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Michikawa,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C."

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.449: (1999) Cholesterol-dependent generation of a seeding amyloid -protein in cell culture. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cholesterol-dependent generation of a seeding amyloid -protein in cell culture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079411:Generation [Temporal Concept]
   738   C3146294:Generation [Activity]
Processing 00000000.tx.450: J. 

Phrase: "J."
Processing 00000000.tx.451: Biol. 

Phrase: "Biol."
Processing 00000000.tx.452: Chem., 274, 1511015114.[Abstract/Free FullText] 58 Howland, D.S., Trusko, S.P., Savage, M.J., Reaume, A.G., Lang, D.M., Hirsch, J.D., Maeda, N., Siman, R., Greenberg, B.D., Scott, R.W. and Flood, D.G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "1511015114."

Phrase: "[Abstract/Free FullText"

Phrase: "] 58 Howland,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Trusko,"

Phrase: "S.P.,"

Phrase: "Savage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331893:Savage [Health Care Related Organization]

Phrase: "M."

Phrase: "J.,"

Phrase: "Reaume,"

Phrase: "A.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lang,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Hirsch,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Maeda,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Scott,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Flood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016248:Flood [Natural Phenomenon or Process]
  1000   C0375741:Flood [Injury or Poisoning]

Phrase: "D."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.453: (1998) Modulation of secreted -amyloid precursor protein and amyloid -peptide in brain by cholesterol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Modulation of secreted -amyloid precursor protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "amyloid -peptide in brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by cholesterol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]
Processing 00000000.tx.454: J. 

Phrase: "J."
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Chem., 273, 1657616582.[Abstract/Free FullText] 59 Price, D.L., Tanzi, R.E., Borchelt, D.R. and Sisodia, S.S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "1657616582."

Phrase: "[Abstract/Free FullText"

Phrase: "] 59 Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L., Tanzi,"

Phrase: "R.E.,"

Phrase: "Borchelt,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.457: (1998) Alzheimers disease: genetic studies and transgenic models. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "transgenic models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1519606:Transgenic Model [Experimental Model of Disease]
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.458: Annu. 

Phrase: "Annu."
Processing 00000000.tx.459: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.460: Genet., 32, 461493.[ISI][Medline] 60 Lamb, B.T., Bardel, K.A., Kulnane, L.S., Anderson, J.J., Holtz, G., Wagner, S.L., Sisodia, S.S. and Hoeger, E.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "32,"

Phrase: "461493."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 60 Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0452875:Lamb [Food]
   861   C1123019:lamb [Mammal]
   861   C1145701:L-AmB [Antibiotic,Organic Chemical]
   861   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "B.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "Bardel,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kulnane,"

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "J.J.,"

Phrase: "Holtz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wagner,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Hoeger,"

Phrase: "E.J."
Processing 00000000.tx.461: (1999) Amyloid production and deposition in mutant amyloid presursor protein and presenilin-1 yeast artificial chromosome transgenic mice. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Amyloid production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "deposition in mutant amyloid presursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "presenilin-1 yeast artificial chromosome transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
Processing 00000000.tx.462: Nature Neurosci., 2, 695697.[ISI][Medline] 61 Kida, E., Pluta, R., Lossinsky, A.S., Golabek, A.A., Choi-Miura, N.-H., Wisniewski, H.M. and Mossakowski, M.J. 

Phrase: "Nature Neurosci.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "695697."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 61 Kida,"

Phrase: "E.,"

Phrase: "Pluta,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lossinsky,"

Phrase: "A.S.,"

Phrase: "Golabek,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Choi-Miura,"

Phrase: "N.-H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Wisniewski,"

Phrase: "H.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348952:H/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mossakowski,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.463: (1995) Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Complete cerebral ischemia with short-term survival"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0007785:Cerebral Ischemia [Disease or Syndrome]
   778   C0917798:Cerebral Ischemia [Disease or Syndrome]
   748   C0022116:Ischaemia [Disease or Syndrome]
   748   C0205197:Complete [Qualitative Concept]
   748   C0725685:COMPLEAT [Food]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "induced by cardiac arrest."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   881   C0018791:Cardiac Arrest, Induced [Therapeutic or Preventive Procedure]
   833   C0018790:Cardiac Arrest [Disease or Syndrome]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C0205263:Induced [Functional Concept]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C1522601:Cardiac [Spatial Concept]
   715 E C0311403:Inhibited [Qualitative Concept]
   715 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.464: II. 

Phrase: "II."
Processing 00000000.tx.465: Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. 

Phrase: "Extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "and"

Phrase: "intracellular accumulation of apolipoproteins E"

Phrase: "and"

Phrase: "J in the brain."
Processing 00000000.tx.466: Brain Res., 674, 341346.[ISI][Medline] 62 Nicoll, J.A.R., Roberts, G.W. and Graham, D.I. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "674,"

Phrase: "341346."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 62 Nicoll,"

Phrase: "J.A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G.W."

Phrase: "and"

Phrase: "Graham,"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.467: (1995) Apolipoprotein E 4 allele is associated with deposition of amyloid -protein following head injury. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "associated with deposition of amyloid -protein"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   814   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0333562:Deposition [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "head injury."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0018674:Head injury [Injury or Poisoning]
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
   805 E C0205096:Cephalic [Spatial Concept]
Processing 00000000.tx.468: Nature Med., 1, 135137.[ISI][Medline] 63 Fagan, A.M., Murphy, B.A., Patel, S.N., Kilbridge, J.F., Mobley, W.C., Bu, G. and Holtzman, D.M. 

Phrase: "Nature Med.,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "135137."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 63 Fagan,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Murphy,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Patel,"

Phrase: "S."

Phrase: "N., Kilbridge,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mobley,"

Phrase: "W.C., Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: (1998) Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (/) mice but impaired clearance of axonal degeneration products following injury. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Evidence for normal aging of the septo-hippocampal cholinergic system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(/"

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "but"

Phrase: "impaired clearance of axonal degeneration products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.470: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.471: Neurol., 151, 314325.[ISI][Medline] 64 Edmond, J., Korsak, R.A., Morrow, J.W., Torok-Both, G. and Catlin, D.H. 

Phrase: "Neurol.,"

Phrase: "151,"

Phrase: "314325."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 64 Edmond,"

Phrase: "J.,"

Phrase: "Korsak,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Morrow,"

Phrase: "J.W., Torok-"

Phrase: "Both,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Catlin,"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.472: (1991) Dietary cholesterol and the origin of cholesterol in the brain of developing rats. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Dietary cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008395:Cholesterol, Dietary [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "the origin of cholesterol"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0079946:origin [Classification]
   770   C0439659:Origin [Temporal Concept]
   770   C1550512:origin [Intellectual Product]
   715 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   715 E C0314603:Genetic [Functional Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of developing rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.473: J. 

Phrase: "J."
Processing 00000000.tx.474: Nutr., 121, 13231330.[ISI][Medline] 65 Sperk, G. 

Phrase: "Nutr.,"

Phrase: "121,"

Phrase: "13231330."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 65 Sperk,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.475: (1993) Kainic acid seizures in the rat. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Kainic acid seizures in the rat."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0036572:Seizures [Sign or Symptom]
   719 E C1959629:Seizure [Finding]
Processing 00000000.tx.476: Prog. 

Phrase: "Prog."
Processing 00000000.tx.477: Neurobiol., 42, 132.[ISI] 66 Cotman, C.W. and Nieto-Sampedro, M. 

Phrase: "Neurobiol.,"

Phrase: "42,"

Phrase: "132."

Phrase: "[ISI] 66 Cotman,"

Phrase: "C.W."

Phrase: "and"

Phrase: "Nieto-Sampedro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: (1984) Cell biology of synaptic plasticity. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Cell biology of synaptic plasticity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
Processing 00000000.tx.479: Science, 225, 12871294.[ISI][Medline] 67 Arendt, T., Schindler, C., Brckner, M.K., Eschrich, K., Bigl, V., Zedlick, D. and Marcova, L. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "225,"

Phrase: "12871294."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 67 Arendt,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schindler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Brckner,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eschrich,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bigl,"

Phrase: "V.,"

Phrase: "Zedlick,"

Phrase: "D."

Phrase: "and"

Phrase: "Marcova,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.480: (1997) Plastic neuronal remodeling is impaired in patients with Alzheimers disease carrying apolipoprotein 4 allele. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Plastic neuronal remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1160367:neuronal remodeling [Organ or Tissue Function]

Phrase: "is"

Phrase: "impaired in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]

Phrase: "with Alzheimers disease carrying apolipoprotein 4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.481: J.

Phrase: "J."
Processing 00000000.tx.482: Neurosci., 17, 516529.[Abstract/Free FullText] 68 McLean, J.W., Elshourbagy, N.A., Chang, D.J., Mahley, R.W. and Taylor, J.M. 

Phrase: "Neurosci.,"

Phrase: "17,"

Phrase: "516529."

Phrase: "[Abstract/Free FullText"

Phrase: "] 68 McLean,"

Phrase: "J.W., Elshourbagy,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Chang,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.483: (1984) Human apolipoprotein E mRNA. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Human apolipoprotein E mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.484: cDNA cloning and nucleotide sequencing of a new variant. 

Phrase: "cDNA cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "nucleotide sequencing of a new variant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004793:nucleotide sequencing [Nucleotide Sequence]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.485: J. 

Phrase: "J."
Processing 00000000.tx.486: Biol. 

Phrase: "Biol."
Processing 00000000.tx.487: Chem., 259, 64986504.[Abstract/Free FullText] 69 Kitamoto, T., Nakamura, K., Nakao, K., Shibuya, S., Shin, R.-W., Gondo, Y., Katsuki, M. and Tateishi, J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "259,"

Phrase: "64986504."

Phrase: "[Abstract/Free FullText"

Phrase: "] 69 Kitamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakamura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakao,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shibuya,"

Phrase: "S."

Phrase: ","

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "R.-W., Gondo,"

Phrase: "Y.,"

Phrase: "Katsuki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Tateishi,"

Phrase: "J."
Processing 00000000.tx.488: (1996) Humanized prion protein knock-in by cre-induced site-specific recombination in the mouse. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Humanized prion protein knock-in by cre-induced site-specific recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1517676:Knock-in [Research Activity]

Phrase: "in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.489: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.490: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.491: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.492: Commun., 222, 742747.[ISI][Medline] 70 Thomas, K.R. and Capecchi, M.R. 

Phrase: "Commun.,"

Phrase: "222,"

Phrase: "742747."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 70 Thomas,"

Phrase: "K.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Capecchi,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Site-directed mutagenesis by gene targeting"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   753   C0079866:Mutagenesis [Molecular Function]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   753   C3146302:Mutagenesis [Laboratory Procedure]
   750   C1550500:direct target [Idea or Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "in mouse embryo-derived stem cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   894   C1514965:Mouse Stem Cell [Cell]
   858   C0920487:embryo cell [Embryonic Structure]
   840   C0038250:Stem cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0242767:Stem [Plant]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.494: Cell, 51, 503512.[ISI][Medline]

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "51,"

Phrase: "503512."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

